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Abstract 
Pressure ulcers (PrU) are a secondary health complication that cause increased morbidity, 
mortality and decreased quality of life.  PrUs have also been shown to have a significant 
financial burden on the healthcare system.  Current best practice guidelines strongly 
recommend the use of electrical stimulation (E-Stim) to increase healing rates of PrUs.  
Unfortunately, there has been lack of uptake for the use of E-Stim in clinical practice.  To 
address this gap in practice, a knowledge mobilization project called the E-Stim 
Collaboration Project was developed.  The aim of this dissertation was to 1) determine if 
an education program can change knowledge, attitudes and practice (KAP) in a variety of 
health care providers providing care to people with PrUs, 2) the cost effectiveness of E-
Stim, and 3) estimate the cost of PrU treatment in community dwelling individuals.    
Chapter 2 outlines an education program that was developed for health care providers 
(n=83) to determine whether KAP can be improved for the use of E-Stim in individuals 
with chronic wounds.  Knowledge and attitudes were found to be significantly increased 
after the education program, certain attitudes changed after a hands-on workshop, 
however practice change only occurred in 39% of participants.  Chapter 3 evaluates the 
cost effectiveness of E-Stim using decision analytic modelling to determine the cost per 
quality-adjusted life year (QALY).  The model results showed that E-Stim is a cost-
effective treatment for this patient population especially when compared to a more 
commonly used advanced wound therapy called negative pressure wound therapy.  In 
Chapters 4 and 5, the cost of living in the community with a PrU is estimated from a 
health care and societal perspective using current PrU treatment methods and showed an 
average cost of $8247.48 per month which can be as high as $37,873.65 per month when 
a person develops osteomyelitis in the bone underlying their PrU.  Health care costs spent 
to date on the 22 study participants who had their PrU for an average of 21.2 months was 
approximately $3,846,624.50.  Using advanced wound therapies such as E-Stim are 
known to speed healing and avoid complications is warranted and cost effective.  
Keywords 
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1 Thesis Introduction 
The aim of this doctoral research is to improve wound care treatment for patients living 
in the community with mobility impairment and pressure ulcers (PrU).  A PrU is a 
localized injury to the skin and/or underlying tissue usually over a bony prominence due 
to pressure, or pressure in combination with shear. The severity and depth of PrUs has 
been characterized by the National Pressure Ulcer Advisory Panel (NPUAP) using a 
staging system of I-IV.1  Stage III and IV PrUs indicate a deeper wound.  PrUs are a 
prevalent secondary health complication for individuals with mobility impairment.  In a 
2004 Canadian prevalence study, it was reported that 26% of institutionalized patients 
suffer with a PrU.2  In a Canadian Institute for Health Information (CIHI) report using the 
discharge abstract database (DAD), a database which captures clinical information based 
on physician hospital discharge summaries, the prevalence of PrUs in the community was 
estimated to be 2.4%.  This was assumed to be an underestimate due to lack of reporting.3  
The cost of treating PrUs is also significant.  A conservative estimate of annual costs for 
wound care treatment in Ontario is $1.5 billion with PrUs and surgical wound infections 
costing each Canadian hospital more than $1 million per year.4,5  Research has also 
shown that hospital costs can range from $11,000 to as high as $90 000 for a single PrU.6   
However, these costs are based on administrative databases which are known to be 
flawed.   
Multiple best practice guidelines have been developed to guide clinicians in the 
management of PrUs.  Best practice guidelines utilize a systematic approach to evaluate 
treatment evidence and assist health care providers in making treatment decisions.  
International, national, and local best practice guidelines for the treatment of PrUs have 
made recommendations for the use of advanced therapies to speed the closure of PrUs.7–9  
Advanced therapies is the term used for modalities that are utilized when standard 
practices may not be adequate for wound healing.10  The advanced therapy which has the 
highest level of evidence for the treatment of PrUs is electrical stimulation (E-Stim).11  E-
Stim involves the placement of electrodes in or around a wound to deliver a small current 
to the wound bed.  By delivering this current to the wound, several wound healing 
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processes are stimulated and optimized.  Despite the vast amounts of evidence in the 
literature supporting the use of E-Stim for PrU healing in multiple best practice 
guidelines7-9 there has been lack of uptake for its use in hospitals, long term care or the 
community.  
To address the need for the implementation of E-Stim from “bench to bedside”, a 
knowledge mobilization project called the E-Stim Collaboration Project was initiated.  
Researchers collaborated with stakeholders from the hospital, long term care, and 
community sectors to develop resources and pathways to increase the use of E-Stim as an 
evidence-based intervention for PrU treatment.  The aim of the E-Stim Collaboration 
Project was to develop and sustain a comprehensive approach to delivering E-Stim that 
could be replicated in different healthcare and community settings across Canada.  As 
part of this multi-year project, several facilitators and barriers were identified during the 
first phase of the project.12  Two of the main themes identified as barriers for the uptake 
of E-Stim included lack of knowledge and education, and concerns about expense (i.e. 
cost of treatment).   The focus of this thesis was to develop and evaluate an educational 
framework for the implementation of E-Stim, and to analyze the costs associated with 
living in the community with a PrU as part of the E-Stim Collaboration Project.   
The E-Stim Collaboration Project used a model of care that was based on Knowledge to 
Action (KTA) and National Implementation Research Network (NIRN) frameworks to 
ensure the facilitation of knowledge translation into practice.12  This was completed using 
plan, do, study act (PDSA) cycles to have an informed process for E-Stim 
implementation.  A total of five cycles were completed over a two year and nine month 
time period.  A detailed account of the E-Stim Collaboration Project and its use of 
knowledge frameworks has been documented in the literature by Lala et al (2018).13   
1.1 Educational Programs:  Pressure Ulcer Prevention 
A literature review was conducted to explore educational programs that have been 
developed and evaluated for PrUs.  Gunningberg in 2004 investigated the effect of a PrU 
prevention program with 20- registered nurses (RNs) from hospital and community 
settings in Uppsala, Sweden.14  Knowledge, as well as documentation and prevention 
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strategies, were assessed immediately before and after an educational program, as well as 
eight months after attending the educational program.  Knowledge was measured using a 
questionnaire and documentation was evaluated by conducting chart reviews.  PrU 
prevention strategies used by nurses were assessed by interviewing the head nurse before 
and eight months after the education program to determine nursing change in practice.  
The educational program delivered by Gunningberg consisted of a multidisciplinary team 
approach and included 40 hours of lecture and 40 hours of practice.  The authors found a 
significant increase in knowledge about PrU prevention after the educational program.  
At eight-month follow-up, 55% of the RNs had implemented new routines based on the 
education they received.  Documentation on patient risks and treatment interventions for 
the prevention of PrUs was still lacking after the program.    
Sinclair et al, 2004 assessed the difference in knowledge between RNs and licensed 
practical nurses (LPNs) immediately after and three months following a PrU prevention 
workshop.15  Five hundred, ninety-five RNs and 59LPNs who worked at one of three 
hospitals in Calgary, Alberta, Canada participated in the study.  The researchers assessed 
change in knowledge using a modified version of the Pressure Ulcer Knowledge 
Assessment Tool (PUKAT) which included 53items on PrU staging, wound description 
and risk assessment and prevention.16  Knowledge was significantly higher after 
attending the 3.5hr workshop compared to pre-workshop scores.  There was a decrease in 
knowledge in the three months follow up scores in relation to the scores immediately 
after the workshop.  The authors concluded that the education for evidence-based practice 
in PrU prevention is effective and suggested that ongoing staff education for PrU 
prevention and treatment is both necessary and important.  
Results from prior studies support the need for educational programs to increase 
knowledge for PrU prevention, however, an increase in knowledge does not always lead 
to a change in practice.14,15  In order to further evaluate comprehension of PrU 
prevention, knowledge, attitude, and practice (KAP) surveys have been utilized to assess 
individual’s behaviour.  KAP surveys identify what people know (knowledge), how they 
feel (attitude) and what they do (practice).17  Kallman and Suserud (2009) used a 
questionnaire consisting of 47 items designed to assess RNs and nursing assistants (NAs) 
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knowledge, attitudes and practices as well as perceived possibilities and barriers 
regarding PrU prevention.18  Two hundred and thirty questionnaires were distributed in 
both community and hospital care settings in the western part of Sweden.  Sixty-seven 
percent of participants responded, and the authors found that nursing staff had a positive 
attitude regarding PrU prevention.  They reported that nurses had a generally good 
knowledge about prevention and the treatment of pressure injuries, although in terms of 
practice only 37% (n=55) of the participants said that they have a strategy in place for 
PrU prevention at their place of work.  The authors concluded that given the low number 
of reported PrU prevention strategies, this may adversely affect the quality of care 
provided to the patients and lead to PrU development.   
Strand and Lindgren in 2010, distributed a questionnaire to assess nurses knowledge, 
attitudes and perceived barriers and opportunities towards PrU prevention in an intensive 
care unit (ICU) setting in a Swedish hospital.19  A total of 315 questionnaires were 
distributed and 146(46%) were completed and returned for evaluation.  PrU staging was 
correctly made by only 47% of respondents and the authors noted that several 
respondents did not answer some of the knowledge questions.  Perceived barriers to PrU 
prevention included lack of time for interventions such as turning schedules, and severely 
ill patients in the ICU setting.  Opportunities for knowledge and access to pressure 
relieving equipment were most commonly reported as facilitators for best practices.  The 
authors concluded that raising knowledge among nursing staff as well as making PrU 
prevention a priority in daily care is an important organizational challenge in the ICU.   
Demarre et al(2011) completed a cross-sectional multi-centre study to evaluate the 
association between knowledge and attitudes of nurses and nursing assistants, and 
compliance with PrU prevention guidelines in residents at long term care homes in 
Belgium.20  PrU prevention was defined as fully compliant if all preventative measures in 
bed and when seated were applied, partly compliant if some measures were applied in 
bed and/or while seated, and no prevention compliance if there was a total absence of any 
adequate preventative measure.  Knowledge and attitude was assessed using a random 
sample of at least five nurses from 18 participating long-term care wards.  The PUKAT 
and Attitude towards Pressure Ulcers (APuP) instrument were used, both of which have 
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been validated in the literature.16,21  One hundred and forty-five nurses and nursing 
assistants were included, and compliance with the guidelines was evaluated in 
615residents.  The mean knowledge scores were 29% for nurses and 29% for nursing 
assistants.  The overall attitude score was 75%.  The authors concluded that attitudes of 
nurses and nursing assistants towards pressure injuries were strongly associated with the 
application of fully compliant PrU prevention guidelines, while knowledge was not.   
Cullen-Gill et al in 2013 also used the PUKAT and APuP instruments to evaluate the 
knowledge and attitudes of fourth-year undergraduate nurses towards PrU prevention.22  
A quantitative cross-sectional survey design of 60 undergraduate nurses revealed that 
nursing students had an overall positive attitude towards PrU prevention, but a poor 
knowledge of PrU prevention methods.  Simonetti et al(2015) assessed a total of 742 
nursing student’s knowledge and attitudes on PrU prevention using the PUKAT and 
APuP in seven Italian nursing schools.23  The overall knowledge scores were 51% and 
attitude scores were 77%.  The authors found a weak correlation between total knowledge 
scores and total attitude scores and concluded that their results suggested that positive 
attitudes toward PrU prevention may contribute to the compliance with clinical practice 
guidelines in PrU prevention.   
Review of the existing literature revealed that PrU prevention educational programs have 
been well studied; however, there are gaps in terms of PrU treatment educational 
programs.  Research also suggests there may be a disconnect between having the 
knowledge about what to do and implementing that new knowledge into practice.   Based 
on the findings of the literature review, an educational framework was developed and 
delivered as part of the E-Stim Collaboration Project and knowledge, attitudes, and 
practice were measured before and after completing the educational program (see 
Chapter 2).   
1.2 Cost of Pressure Ulcers 
To be successful in the implementation of an advanced therapy in the current healthcare 
climate, knowledge of its use and effectiveness is not enough to influence a change in 
practice.  Costs associated with treatments and how one advanced therapy may be more 
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cost effective than a comparator is an important factor to influence change.  Treatment 
effectiveness as well as cost benefit through cost analysis is required to engage health 
care providers, stakeholders and decision makers.   
To address the question of costs associated with interventions for the treatment of PrUs, a 
literature search was conducted  for economic analysis evaluations that have been 
completed on interventions to speed the healing of PrUs.  Three systematic reviews were 
found that have synthesized information on the cost-effectiveness for the treatment of 
PrUs.24–26  Tricco et al(2015) sought  to elucidate cost-effective treatment strategies for 
all types of complex wounds.24  Fifty-nine cost-effectiveness studies were included in the 
systematic review, with 14 of the included studies evaluating interventions for the 
treatment of PrUs.27-40  Of the 14 included studies, 10 evaluated the cost effectiveness of 
PrU dressings 28-30,32,34-38,41, one evaluated the cost effectiveness of growth factors in PrU 
healing31, one evaluated the cost-effectiveness of a specialized nursing intervention 
program on the healing of PrUs39, and two evaluated the cost effectiveness of pressure 
management surfaces on the treatment of PrUs.27,33  Of these included studies, three 
interventions were found to be dominant (more effective and less costly)for the treatment 
of PrUs.  The dominant treatments included moisture vapor permeable dressing vs. 
gauze, advanced dressings vs. gauze, and hydrocolloid vs. gauze.    
In 2014 Carter conducted a systematic review of literature that addressed the economic 
evaluation of guideline-based or strategic interventions for the prevention or treatment of 
chronic wounds and identified two studies that assessed the cost effectiveness of PrU 
management.26   The first study evaluated the cost effectiveness of a PrU dressing41 and 
the second evaluated the cost effectiveness of an incentive strategy for the treatment of 
PrUs.43  Palfreyman and Stone(2014) completed a systematic review of economic 
evaluations assessing interventions aimed at preventing or treating PrUs.  They found 23 
studies for inclusion in the analysis, 11 of which were specific for PrU 
treatment.33,35,36,38,41,42,44-48  Eight studies evaluated the cost effectiveness of dressings on 
PrU management35,36,38,42,45,46,48, two evaluated the cost effectiveness of pressure 
managing surfaces for the treatment of PrUs33,44, and one study evaluated the cost 
effectiveness of E-Stim for the treatment of PrUs.47  The majority of the studies had ulcer 
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healing as the primary outcome measure but one used rate of healing.36  Conclusions 
from both systematic reviews were similar reporting that there is a plethora of evidence 
based best practice guidelines for the treatment of PrUs, however evidence of cost-
effectiveness for various interventions is lacking.    
In review of the literature, only one cost-effectiveness study for the evaluation of E-Stim 
for the treatment of PrUs was identified.  The study by Mittmann et al, 2011 evaluated 
the incremental cost-effectiveness of E-Stim plus standard wound care (SWC) versus 
SWC alone in a spinal cord ulcer population with stage III/IV PrUs in Ontario, Canada 
from the public payer perspective.47  A decision analytic model was constructed for a 
one-year time horizon.  Model inputs for the clinical probabilities and direct health 
system and medical resources were based on a randomized controlled trial of E-Stim plus 
SWC versus SWC alone.49  They found that E-Stim plus SWC were associated with 
better outcomes and lower costs than SWC alone.  There was a 16.4% increase in the 
PrUs healed and a cost saving of $224 at one year.  Therefore, E-Stim plus SWC was 
considered a dominant strategy.  Despite this evaluation, E-Stim continues to be 
underutilized as an advanced therapy for PrU treatment.   
This thesis will focus on the education and cost aspects of the E-Stim Collaboration 
Project, a large, multi-sector knowledge mobilization project conducted in the South 
West Local Health Integration Network (LHIN).  Chapter 2 reports on the evaluation of 
the educational program developed for health care providers to address the gap of 
knowledge and awareness for the use of E-Stim for PrU treatment.  Chapter 3 is a cost 
analysis using modelling to compare the advanced therapy of E-Stim to another 
commonly used advanced therapy; negative pressure wound therapy (NPWT). Chapter 4 
estimates the costs of living in the community with a mobility impairment and PrU to 
establish baseline data prior to intervention.  Chapter 5 is a case study estimating the cost 
of an individual with an SCI and PrU with underlying osteomyelitis.  
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2 Evaluation of an Education Program for the use of Electrical 
Stimulation Therapy to Heal Pressure Ulcers 
2.1 Introduction 
Pressure ulcers (PrU) are a common complication occurring across all sectors of health 
care including hospitals, long term care, and home and community care.1,2  PrUs result in 
a decreased quality of life3–5 and increased mortality rates.6–8  PrUs also cause a large 
financial burden to the health care system.  It has been estimated that PrU care can have a 
monthly cost of $4,750 CDN for individuals with a spinal cord injury who live in the 
community, and the hospital cost of a single PrU can range from $11,000 to $90,000 
CAN.9–11  Given the high cost to patients and the health care system, it is imperative that 
evidence-based interventions are utilized to maximize healing rates in patients with a 
PrU.     
Electrical stimulation (E-Stim) involves applying low levels of electrical current in or 
around a wound for the purpose of promoting wound closure.12–15  E-Stim is strongly 
recommended for the treatment of PrUs and had the highest level of evidence (level 1a)16 
in several national and international best practice guidelines.17–20 Despite having the 
highest level of evidence, there has been little uptake for the use of E-Stim in clinical 
practice.  One of the perceived barriers to the implementation of E-Stim is the lack of 
competency in providing the treatment in the community which is associated with the 
lack of awareness of E-Stim, lack of knowledge, and lack of training and skill.21 
Educational programs about PrU prevention have been well studied; however, there is 
limited information about implementation of treatment programs for PrUs.  To date, the 
impact of educational programs on knowledge, attitudes and practices (KAP) of 
practitioners have focused on the nursing profession and implementing practices that 
address pressure ulcer prevention. Additionally, previous studies have evaluated change 
in knowledge over time, but none of the studies measuring KAP reassessed the effect that 
an educational intervention had on these attributes.22–28  
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Gunningberg (2004) and Sinclair et al (2004) investigated the effects of a PrU prevention 
educational program with nurses.  Both studies found a significant increase in nurse’s 
knowledge immediately after the educational programs, however the knowledge gained 
was not sustained when re-evaluated several months later.22,23  These findings suggest 
that education on PrU prevention is effective but requires ongoing staff education to 
ensure continued knowledge.  Research has also shown that an increase in knowledge 
does not always lead to a change in practice.  To further evaluate comprehension of PrU 
prevention, KAP surveys have been developed.  KAP surveys identify what people know 
(knowledge), how they feel (attitude) and what they do (practice).29  Kallman and 
Suserud(2009) used a KAP survey and found that nursing staff as a whole had a positive 
attitude and good knowledge about prevention and the treatment of PrUs; however, 
results relating to practice were poorer.24  They concluded that without a change in 
practice, the quality of care provided to patients may be adversely affected and lead to 
PrU development.   
Strand and Lindgren in 2010 used a questionnaire to assess nurses knowledge, attitudes 
and perceived barriers and opportunities towards PrU prevention.  They found 
educational opportunities and access to pressure relieving equipment were most 
commonly reported as ways to improve PrU prevention.27  Demarre et al(2011) examined 
the correlation between the knowledge and attitudes of a random sample of RNs and 
nursing assistants (NAs) working in long term care homes.30  Knowledge and attitudes 
were measured using the previously validated Pressure Ulcer Knowledge Assessment 
Tool (PUKAT) and the Attitude towards Pressure Ulcers (APuP) instruments.31,32  The 
mean knowledge scores for RNs and NAs were relatively low (less than 30%) while 
attitude scores were high (74.5%).  The authors concluded that attitudes of RNs and NAs 
towards PrUs were significantly correlated with the application of PrU prevention 
guidelines, while knowledge was not.  Collectively these studies suggest that positive 
attitudes toward PrU prevention may contribute to compliance with clinical practice 
guidelines in PrU prevention more than knowledge scores.   
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The purpose of this study was to determine if an educational program can change KAP in 
a variety of health care providers providing care to people with PrUs living at home.  
Specifically, we set out to identify: 
a) Negative attitudes for the use of E-Stim which may impact its clinical use; 
b) The outcome of an online educational program on knowledge and attitudes; 
c) The outcome of a hands-on workshop on knowledge and attitudes; and 
d) If participation in an educational program can translate to a change in practice.   
 
2.2 Setting 
 The educational program described in this article was developed as part of a multi-year 
knowledge mobilization project aimed to implement E-Stim for treating pressure injuries 
in community dwelling individuals with spinal cord injury (SCI) living in one region of 
Ontario, Canada.  Within this region, health care is coordinated by the South West Local 
Health Integrated Network (South West LHIN) which is funded by the Ministry of Health 
and Long-Term Care.   The South West LHIN provides home care services by 
contracting several provider agencies that employ nurses, allied health professionals, as 
well as unregulated support workers.  The overall aim of the E-Stim Collaboration 
Project was to support home care services of the South West LHIN in a way that 
promoted uptake and use of E-Stim therapy in a sustainable way.  This portion of the 
project will focus on how we addressed the lack of information and training about E-Stim 
that was identified as a barrier during a pre-implementation environmental scan.21      
2.3 Methods 
The quasi experimental design involved healthcare providers from different disciplines 
who volunteered to participate in the educational program. Participants’ knowledge and 
attitude was measured at three points: 1) Pre-Education, 2) Post-Online and 3) Post-
Workshop.  Participants’ change in practice was assessed six months after receiving the 
hands-on education. 
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2.3.1 Subjects 
  As part of the E-Stim Collaboration Project, an awareness campaign was conducted to 
engage providers in all healthcare sectors including the community, homecare, long term 
care, hospitals and private clinics in the South West LHIN.  Multiple agencies with a 
variety of healthcare providers were visited by a research team member who provided 
information about the E-Stim Collaboration Project and invited them to participate in the 
E-Stim Education Program.  Participation in the education program was not limited to 
healthcare providers within the South West LHIN.  The South West LHIN home and 
community care (HCC) providers had access to E-Stim equipment and supplies through 
previously established vendor contracts.   
All the participants who took part in the educational program signed written consent after 
reading a letter of information.  The study was approved by the ethics review committee 
of Western University Health Science Research Ethics Board of London, Ontario, 
Canada (HSREB File Number 107778, Appendix 1).  Informed written consent was 
obtained from all participants to share pooled results of completed tests and surveys 
(Appendix 2). Before beginning the education, demographic information was collected 
about the participants professional background, education and experience in providing 
wound care (see Table 1). 
 
 
 
 
 
 
 
 
18 
 
 
Table 1:  Participant Demographic Data (n=74)   
Profession N % Province N % 
Registered Nurse 32 43 Ontario 70 95 
Physiotherapist 20 27 Alberta 2 3 
Enterostomal Therapist 8 11 Newfoundland 1 1 
Occupational Therapist 6 8 Nova Scotia 1 1 
Registered Nurse Practitioner 5 7 Percent of role in wound care   
Other 2 3 < 25 33 45 
Physician 1 1 25-49 22 30 
Experience, year   50-74 9 12 
0-5  21 28 75-99 8 11 
5-10 16 22 100 1 1 
10-15 6 8 Work Hours   
More than 15 30 41 Full time 58 78 
Sector   Part time 14 19 
Hospital 41 55 Casual 1 1 
Home Care 16 22 Other 1 1 
Clinic 5 7 Level of Wound Education   
Long Term Care 4 5 In-services 19 26 
More than one of above 8 11 1-2-day workshops 23 31 
Role in Wound Care   Enterostomal Therapy 
Certificate 
9 12 
Direct 50 70 Certificate Program 7 9 
Indirect 15 20 Master’s level 7 9 
Organizational Support 4 5 Other 9 12 
None of the above 4 5    
 
2.3.2 Education Program 
An education program for the use of E-Stim on PrUs was developed to address key 
competencies for skilled application.  The education program was delivered in two 
phases: online modules and a hands-on workshop.  The educational program was 
developed based on prior consultation with key stakeholders who identified perceived 
facilitators and barriers of implementing E-Stim for PrU healing.21  Many stakeholders 
stated that there was lack of awareness, knowledge, training, and skills surrounding the 
use of E-Stim.  The stakeholders expressed a preference for open educational resources 
that would be freely accessible online and available in print, in addition to hands-on 
demonstrations on how to use E-Stim.21 
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2.3.3 Online Modules 
The modules were completed using a secure online learning platform associated with 
Western University and were developed to allow participants to review material at their 
own pace and on their own schedule.   Online learning allowed for increased access for 
participants, and modules could be reviewed as needed.   The online modules consisted of 
background theory and knowledge using narrated PowerPoint presentations that were 
organized into eight recorded lectures totaling approximately four hours.  See Table 2 for 
a description of the content contained in the eight modules.   
Table 2:  Online Module Descriptions 
Module 
Number 
Summary 
1.  Overview of the course content and pre-requisite information including 
wound healing principles, best practice guidelines, wound bed preparation, 
wound assessment and aseptic technique. 
2.  The history of E-Stim, basic overview of what E-Stim is, and different types of 
equipment for E-Stim delivery.   
3.  Review of the biological mechanisms and physiological processes that speed 
the healing process with the use of E-Stim. 
4.  Clinical research evidence and clinical practice guidelines for the use of E-
Stim. 
5.  Indications, precautions and contraindications for the use of E-Stim in 
pressure injuries. 
6.  Overview of dressings that are compatible for use with E-Stim in pressure 
injuries. 
7.  Electrical Principles and stimulus parameters 
8.  A detailed review of application techniques.  Including three 5-7minute 
videos that showed different ways to deliver electrical currents to the wound 
and peri-ulcer skin.  These demonstrations allowed participants to see how to 
apply E-Stim during the workshop as well as later when they needed 
reminders.  
 
2.3.4 Hands-on Workshop 
Once participants completed the online modules, they were invited to participate in one 
of seven hands-on workshops that were offered over a one-year period in different 
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locations.  The hands-on workshop began with a brief overview of the content from the 
online modules.  The main objective for the hands-on workshop was to develop the 
clinical skills required to apply E-Stim to patients with PrUs and included interactive case 
discussions to promote critical thinking and the clinical decision-making judgements 
necessary to use E-Stim in a safe and effective manner.  
The specialized equipment and supplies (electrodes, leads) required for the delivery of E-
Stim to wounds was available during the hands-on workshop.   The first component of 
the workshop was initiated with a demonstration of E-Stim application techniques.   
Wound healing fundamentals including wound bed preparation, wound etiology, and 
aseptic techniques were embedded throughout the hands-on session.17-20   Participants 
were able to actively set up the E-Stim equipment on realistic latex wound models.  They 
also were encouraged to experience the sensation of E-Stim to diminish fears and 
describe expected sensations to their patients.  This was followed by a peer evaluation 
that was supervised by two of the study researchers  to confirm participants completed all 
the application steps in a safe and effective manner.   
The second component of the workshop included a review of wound dressings that are 
compatible with E-Stim.  Participants were exposed to samples of different types of 
wound dressings and products. Selection and rationale of the most appropriate dressing 
for each case was developed via interactive case discussions with the class.  Patient 
scenarios were developed and reviewed during the hands-on workshop to test 
participant’s understanding of electrical principles and how changing the E-Stim set up or 
wound environment can affect electrical current flow.   
At the end of the workshop, the clinicians were invited to participate in a Community of 
Practice which continued to meet monthly to share experiences and discuss challenges 
regarding E-Stim implementation via a secure web-based online video/audio link.  The 
community of practice was developed as part of the E-Stim Collaboration Project and 
provided an online forum to link over 300 clinicians across Canada who are working in 
this field.   
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2.4 Instruments 
2.4.1 Knowledge Test 
Knowledge about principles of electricity, mechanism of action, and research evidence 
was measured using a multiple-choice test.  The knowledge test was either administered 
online where 10 questions were randomly selected from a pool of 25 multiple choice 
questions, or on paper where all 25 questions were included in an in-class quiz (Post-
Workshop).  Knowledge questions were developed by the research team and pilot tested 
during a pre-study education session.     
2.4.2 E-Stim Attitude Survey (EAS) 
An attitude survey was developed by the research team to understand the attitudes 
participants had towards the use of E-Stim on pressure injuries and their willingness to 
incorporate an advanced therapy into practice (Table 3).  The survey was based on the 
APuP test developed by Beeckman et al, 2010.30 
Questions were grouped into three subscales to define participant’s attitude including:   
1. Education: Attitude towards the importance of knowledge and skills for the use of E-
Stim in practice. 
2. Evidence based practice:  Attitude towards research evidence and effectiveness of E-
Stim to stimulate/accelerate the healing of pressure injuries 
3. Resources:  Attitude towards efficiency and equipment needs when using E-Stim in 
clinical practice  
The EAS consisted of 14 items measured on a 5-point Likert scale including Strongly 
Agree, Agree, Neutral, Disagree and Strongly Disagree.  The education subscale 
consisted of 5 items, the evidence-based practice subscale consisted of 4 items, and the 
resources subscale consisted of 5 items.   Internal consistency measured using 
Cronbach’s alpha was calculated for each subscale and found to be acceptable for 
education (α=0.74), evidence-based practice (α=0.76), and resources ( α=0.74). 
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Table 3:  E-Stim Attitude Survey (EAS) 
EDUCATION SUBSCALE 
1. Based on my current knowledge, I am willing to incorporate E-Stim into my current practice.   
2. I am reluctant to use E-Stim because of the high risk of harm to my patients.  
3. I cannot use E-Stim because it is not within my scope of practice. 
4. I do not feel I have the advanced knowledge and skills that are required to apply E-Stim to wounds.   
5. I need more hands-on practice and clinical experience with E-Stim before I could use it in my clinical 
practice. 
EVIDENCE BASED PRACTICE SUBSCALE 
6. Providing E-Stim to patients with delayed wound healing is important. 
7. The individuals I see with open wounds are more appropriate for negative pressure wound therapy 
rather than E-Stim. 
8. The individuals I see with open wounds could benefit from E-Stim. 
9. There is little evidence to support the use of E-Stim for individuals with pressure injuries.   
RESOURCES SUBSCALE   
10. I currently use E-Stim when appropriate for individuals with stalled or non-healing wounds.  
11. I don’t have time to provide E-Stim treatment to my clients.   
12. I have good support from supervisors and managers to use E-Stim in my clinical practice.  
13. The cost to provide E-Stim to patients is too high. 
14. The equipment required to use E-Stim is not available to me.   
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2.4.3 Practice Change 
To assess change in practice, participants were followed up via email six months Post-
Workshop session and asked the following question:  
Since attending the E-Stim Consultant Education, I have used E-Stim for chronic 
would healing on: a) 1-5 patients; b)  6 or more patients; or c)  I have not used E-Stim 
since attending the workshop. 
2.5 Time Course of Evaluations 
Knowledge tests and the EAS survey were evaluated at three time points throughout this 
study; prior to commencing the education (Pre-Education), after completing the online 
modules (Post-Online), and after completing the hands-on workshop (Post-Workshop).  
Tests and surveys were administered electronically via the online education system Pre-
education and Post-Online.  A paper tool was used to evaluate the participant’s 
knowledge and attitudes Post-Workshop. 
2.6 Data Analysis 
Eighty-seven individuals completed both the online modules and the hands-on workshop.  
Of the 87 who completed the education program, 83 individuals were included for data 
analysis.  Four participants were excluded due to missing baseline data.    Demographic 
information describing the type and amount of clinical experience were collated and 
analyzed using descriptive statistics.  See Table 1. 
Knowledge was assessed using the percentage of correct answers on the knowledge test.   
EAS results were converted to numeric scores to analyze the data.   Attitudes were 
assessed using the subscales of education, evidence-based practice, and resources.  To 
evaluate the impact of the education program on knowledge, and on the three subscales 
of the attitude questionnaire, a separate linear mixed effects model was fit to each of the 
four dependent variables.  Time of measurement (Pre-Education, Post-Online, Post-
Workshop) was included in the model as a fixed effect, and participants were included as 
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a random effect. Utilizing a linear mixed effects model allowed us to use all available 
data without the need for list-wise deletion of participants with missing data, or 
interpolation of these missing data points.32   The statistical significance of the fixed 
effect was identified by comparing this model to a ‘null’ model in which the dependent 
variable was predicted only by random error.  In the event of a statistically significant 
fixed effect, post-hoc testing was done by testing all possible pairwise comparisons using 
t-tests with degrees of freedom estimates that were calculated using a Satterthwaite 
approximation.  All statistical analyses were performed in R33, with linear mixed effects 
analyses conducted using the lme434 and lmerTest35 packages.  Post-hoc pairwise 
comparisons were completed using the lsmeans package.36 
2.7 Results 
2.7.1 Demographics 
The majority of the participants were registered nurses (43.2%) followed by 
physiotherapists (27.0%), enterostomal therapists (10.8%), occupational therapists 
(8.1%), registered practical nurses (6.8%), other (2.7%) and one physician (1.4%).  Most 
participants worked in a hospital environment (55.4%) and in a full-time capacity 
(78.4%).  Participants had a variety of background knowledge in wound management but 
the majority (56.8%) had taken either in-services or 1-2-day workshops as their highest 
level of wound care knowledge.      
2.7.2 Change in Knowledge Scores 
Mean scores for the knowledge tests for the three time points are presented in Figure 1.  
Total scores ranged from 20-100% Pre-Education, 50-100% Post-Online and 52-96% 
Post-Workshop.  Using the mixed effects model, the effect of time was statistically 
significant (p < .001).  Post-hoc evaluation showed that there was a statistically 
significant increase in knowledge from Pre-Education to Post-Online,  t (145) = 9.18, p < 
.0001.  Knowledge scores were higher Post-Workshop compared to Pre-Education, t 
(141) = 9.81, p < .0001.  Participants were most challenged by E-Stim knowledge 
questions pertaining to biological mechanisms and the physiological effects of E-Stim.   
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Figure 1:  Knowledge Test Scores;      = significant difference 
 
2.7.3 Change in Attitude Scores 
Baseline attitude scores for the EAS are shown in Figure 2.  Mean scores for the EAS 
subscales of education, evidence-based practice, and resources over time are shown in 
Figure 3.  Post-hoc analysis revealed that there was a significant increase in attitudes 
related to the education subscale over all three time points:  Pre-Education and Post-
Online, t(140)=7.08, p < .05; Pre-education and Post-Workshop, t (136) = 10.98, p < .05; 
and between Post-Online and Post-Workshop surveys, t (140) = 3.13, p < .05.   
For the evidence-based practice subscale, attitudes were significantly increased between 
Pre-Education and Post-Online groups, t (127) = 6.03, p < .05, as well as between Pre-
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Education and Post-Workshop, t (122) = 4.86, p < .05, but not between Post-Online and 
Post-Workshop.   
For the resources subscale, there was also a significant increase in attitudes between Pre-
Education and Post-Workshop, t (113) = 5.22, p < .05, Post-Online and Post-Workshop, t 
(115) = 4.07, p < .05, but not between Pre-Education and Post-Online time points.   
27 
 
 
 
Figure 2:  E-Stim Attitude Survey Pre-Education Program   
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I am reluctant to use E-Stim because of the high risk of harm to
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I do not feel I have the advanced knowledge and skills that are
required to apply E-Stim to wounds.
I need more hands-on practice and clinical experience with E-
Stim before I could use it in my clinical practice.
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28 
 
 
 
Figure 3:  E-Stim Attitude Survey Scores;      = significant difference from Pre-
Education Scores,       = significant difference from Post-Online 
 
2.7.4 Practice Change 
Thirty-three of a potential 83 participants who had completed the hands-on session six 
months prior responded to the practice change question (40% response rate).  Of the 
group that responded, 33% had used E-Stim on 1-5 patients, 6% had used E-Stim on 6 or 
more patients, and 61% had not used E-Stim since attending the workshop.     
2.8 Discussion 
The results of this study have demonstrated that a customized online education program 
increased knowledge about E-Stim in a group of multidisciplinary health care providers.  
Subsequent completion of a hands-on workshop was required to change certain attitudes 
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about E-Stim. Despite being able to increase knowledge and improve attitudes toward E-
Stim, less than half of the responding participants changed their practice six months after 
attending the education program.  
To our knowledge, this is the first research study to evaluate the knowledge, attitudes and 
practices regarding the use of E-Stim by health care providers involved in the treatment 
of PrUs.  Assessment of knowledge and attitudes for the use of an evidence-based 
intervention such as E-Stim is important given the many barriers associated with the 
implementation of evidence-based guidelines.21 Our study showed that a 4-hour online 
education program could significantly improve clinician’s knowledge about E-Stim. 
Clinicians could independently complete this online program when it was convenient, 
and this background information could be referenced in the future when required by the 
clinician. 
Interestingly, there was no further increase in knowledge detected after completion of a 
hands-on session.  This was expected given the theoretical knowledge component of the 
educational program was delivered via online modules and we did not repeat any of the 
background knowledge during the hands-on workshop.  It is also possible that we were 
unable to detect changes in knowledge scores after the hands-on workshop because the 
test was administered differently pre and post workshop.  The paper-based test with all 25 
multiple choice questions that was administered after the workshop may have been more 
difficult than previous tests where only 10 questions were selected randomly.  
The EAS was used to assess whether clinicians would be more willing to incorporate E-
Stim as PrU treatment.  The education subscale, which measured attitudes about the 
importance of E-Stim knowledge, increased after the online education and continued to 
improve after the hands-on workshop.  This demonstrates that attitudes towards the 
importance of E-Stim knowledge can be optimized when a combination of online and 
face to face skills workshop are provided.  In evaluating the attitude pre-education scores, 
69 (83%) participants agreed with the statement “I need more hands-on practice and 
clinical experience with E-Stim before I could use it in my clinical practice.”  Fifty-two 
participants (63%) also agreed with the statement “I do not feel I have the advanced 
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knowledge and skills that are required to apply E-Stim to wounds”.  We were able to 
demonstrate a significant increase in attitudes towards the use of E-Stim after our 
education program, however a hands-on workshop was not sufficient to change 
clinician’s practices.  Further mentorship and education in a clinical setting may be 
required to increase use of E-Stim for PrU treatment.   
The evidence-based practice subscale, which measured attitudes towards research 
evidence and E-Stim effectiveness, increased after completing the online modules but did 
not change after the hands-on workshop.  The lack of change in this portion of the 
attitude survey is likely because information about clinical research and best practice 
recommendations was only included in the online modules, and not part of the hands-on 
workshop.  The resources subscale measured attitudes towards E-Stim efficiency and 
equipment needs and showed that improvements in this attitude did not occur until after 
completing the hands-on workshop.  This is because we provided in the hands-on 
workshop an opportunity for participants to observe and use the specialized equipment 
and supplies that were available to them for E-Stim treatments.     
Previous studies have shown an increase in nurse’s knowledge after educational 
workshops, but did not evaluate attitudes.22,23  The studies that evaluated attitudes, did not 
assess if an educational program could change nurses attitudes.24,25,27,28,35  Our findings 
demonstrate the importance of providing a combination of knowledge and skills, and 
having a hands-on workshop. We were able to overcome these negative attitudes and 
barriers to E-Stim implementation by having the equipment available for participants to 
use during the workshop and have a better understanding of the time and steps required 
for E-Stim set up.  We also required all course participants to demonstrate they were able 
to manipulate the equipment and set up all the supplies appropriately during the hands-on 
workshop.   
Although we found that knowledge and attitudes towards E-Stim improved significantly 
after this education program, only 39% of respondents had used E-Stim in their wound 
care practice six months Post-Workshop.   This relatively low rate of practice change is 
consistent with other reports that showed improved knowledge does not subsequently 
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impact behavior.36   Of the 83 participants, only 33 responded.  With this response rate 
(40.8%) it is unclear whether this relatively low level of E-Stim use is representative of 
the larger group of clinicians who completed the education.  It is possible this rate of 
practice change may be falsely elevated given that participants who used the intervention 
may be more willing to respond to the question.  We did not investigate the reasons why 
participants did not use E-Stim in their practice.  It is possible that they did not receive 
referrals or encounter appropriate patients for E-Stim treatment.     
A lack of translation of knowledge into practice is not uncommon.37–39   Beeckman et al 
in 2011 evaluated the relationship between knowledge, attitudes and the application of 
evidence-informed PrU prevention strategies for nurses working at 14 Belgian hospitals.  
They concluded that nurse’s knowledge about PrU prevention was inadequate and that 
knowledge of prevention methods was not associated with the application of prevention 
methods.  Attitude scores were higher than the knowledge scores and did have a 
significant correlation with evidence-based practices being utilized for patients.   
Previous studies that recorded nurse’s attitudes toward evidence-based practices in PrU 
prevention showed nurses were negatively affected by a lack of resources; more 
specifically lack of time40, lack of nursing staff40,41 and insufficient equipment.41  In our 
study, we know that the equipment and processes needed to provide this E-Stim to 
patients living in this region were in place over this time period.   
The challenge with producing practice change and encouraging clinicians to adopt new 
approaches into clinical care is well documented in the literature.36, 42–45  This has fueled 
the emergence of a new area of research called implementation science.  Despite 
numerous frameworks and established processes to identify and address barriers and 
involve end users, sustained practice change remains elusive.  Our experience suggests 
that filling knowledge gaps and addressing concerns about competency using an 
innovative and very accessible education program is only part of the underlying problem 
with getting new treatments into wound care practice.    
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2.9 Conclusions 
Training is perceived as a barrier for the implementation of evidence-based practice in 
wound healing, specifically for the use of E-Stim in the treatment of pressure injuries.  
Education delivered using online modules that includes theoretical background and a 
critical review of clinical research evidence can increase health care providers  
knowledge about E-Stim and other best practices used in the treatment of PrUs.  A one-
day face to face session which involved practice with hands-on skills was required to 
improve certain attitudes towards E-Stim.  More clinicians who completed this education 
used E-Stim in their practice; however, the rate of practice change remained low.  These 
findings suggest that further intervention is required to change practice patterns, such as 
ongoing coaching and mentorship in the clinical setting. 
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3 Evaluation of the Cost-Effectiveness of Electrical Stimulation 
and Negative Pressure Wound Therapy versus Standard 
Wound Care for the Treatment of Pressure Ulcers 
3.1 Introduction 
Pressure ulcers (PrU) are a common and costly complication occurring across all sectors 
of health care.  In 2013, the Canadian Institute for Health Information (CIHI) reported 
PrU prevalence rates that ranged from 0.4 percent to 14.1 percent in acute care, home 
care, long term care and complex continuing care.1  It has been estimated that PrU care 
can have a monthly cost of $4,750 CDN for individuals with a spinal cord injury who live 
in the community and the cost of a single PrU can range from $11,000 to 90,000 CAN.2-4  
The severity and depth of PrUs has been characterized by the National Pressure Ulcer 
Advisory Panel (NPUAP) using a staging system between I-IV.5  Stage III and IV PrU 
indicate a deeper wound.  Given the high cost to patients and the health care system, it is 
imperative that evidence-based interventions are utilized to maximize healing rates in 
patients with a PrU.  Multiple best practice guidelines have been developed nationally 
and internationally to guide clinicians to implement best practices for the treatment of 
PrU.6–8  Interventions for the management of PrUs include pressure offloading, 
appropriate nutrition, pain management, and local wound care which can include the use 
of advanced therapies such as electrical stimulation (E-Stim) or Negative Pressure 
Wound Therapy (NPWT).  
E-Stim involves the delivery of low-level current via surface electrodes to the area of the 
wound bed for speeding wound closure. Several randomized controlled trials, systematic 
reviews and meta-analyses have concluded that E-Stim can speed healing and promote 
wound closure.9  Despite having strong recommendations to use E-Stim in several best 
practice guidelines, there has been little uptake of the use of E-Stim in clinical practice 
for the treatment of PrUs.6  This may be due to implementation barriers including: lack of 
interdisciplinary collaboration and communication amongst providers between and across 
settings, inadequate training, and lack of resources such as funding, time, and staff.10  To 
address these barriers, a multi-year research project was conducted in community 
dwelling individuals living in one region of Ontario, Canada.  Within this region health 
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care is coordinated by the South West Local Health Integrated Network (South West 
LHIN) that is funded by the Ministry of Health and Long-Term Care (MOHLTC).   The 
South West LHIN provides home care services by contracting several provider agencies 
that employ nurses, allied health professionals, as well as unregulated support workers.   
The E-Stim Collaboration Project was a knowledge mobilization project with the overall 
aim to support home care services of the LHIN in a way that promoted uptake and use of 
E-Stim therapy in a sustainable way.     
Negative pressure wound therapy (NPWT) is an advanced therapy that has been used for 
treating chronic wounds since it was introduced in the early 1990’s.11  NPWT consists of 
a machine which exerts a carefully controlled suction (negative pressure) attached to a 
wound dressing that covers the PrU.  NPWT is a technology that is widely used and is 
promoted for use on many types of wounds but is not recommended by the Registered 
Nurses Association of Ontario (RNAO) best practice guidelines for the treatment and 
management of PrU.6,12   
Despite widespread use of various advanced therapies in wound care, only a limited 
amount of data exists on their cost effectiveness.  In review of the literature, only one 
cost-effectiveness study for the evaluation of E-Stim for the treatment of PrUs was 
identified.  In a study by Mittmann et al (2011), the incremental cost-effectiveness of E-
Stim plus standard wound care (SWC) versus SWC alone was estimated in a spinal cord 
injury population with stage III/IV PrUs from the public payer perspective.13  Cost 
analysis was conducted using the cost data and healing probabilities from a randomized 
controlled trial of E-Stim plus SWC versus SWC alone.14  SWC included using advanced 
wound dressings for local wound treatment.  They found that E-Stim plus SWC were 
associated with better outcomes and lower costs with a 16.4 % increase in the PrUs 
healed and a cost saving of $224 at 1 year.  E-Stim plus SWC had higher effectiveness 
and lower costs than SWC alone and was therefore considered a dominant strategy.15  
Despite this evaluation, E-Stim continues to be underutilized as an advanced therapy for 
PrU treatment.   The study by Mittmann et al demonstrated the benefits of E-Stim using a 
one-year timeline; however, PrUs may be present for many years in clinical practice and 
a one-year analysis may not capture the true value of using E-Stim.    
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The cost effectiveness of NPWT in comparison to advanced wound dressings has been 
investigated.  Braakenburg et al conduced a cost comparison study by assessing the 
clinical efficacy and cost of NPWT versus advanced wound dressings in acute and 
chronic wounds in a hospital in the Netherlands.16  They reported no significant 
difference in healing rates or costs between the two groups.  Dowsett et al also evaluated 
the economic benefits of NPWT in a variety of wound types in the community sector.17  
NPWT use and resources in the community in the United Kingdom was tracked over a 
16-month time period.  They calculated the mean cost per episode (£818) over the 
average number of days for NPWT.  They concluded that the average cost of treating 
complex wounds using NPWT could be significantly less than using traditional dressings 
by saving nursing time to complete the dressing changes.    
Soares et al(2013) conducted a cost-effectiveness analysis on NPWT for the treatment of 
PrUs, recognizing NPWT as a treatment that was widely used for PrUs.18  They evaluated 
the use of NPWT for the treatment of PrUs given a range of alternative treatments using a 
decision analytic model.  A literature search was completed for model inputs and given 
the limited evidence in the literature; the authors also elicited judgments from experts 
using formal elicitation exercises as well as data derived from a pilot trial.19  The three 
sources of evidence were collated and the impact of each on cost-effectiveness was 
evaluated.  They used a model based on three transition states:  unhealed, healed and 
dead.  The authors concluded that when all evidence sources were combined, NPWT was 
expected to be less costly and more effective than advanced dressings alone; however, 
they recommended that a randomized controlled trial with long term follow up would be 
beneficial to reduce decision uncertainty in their model.     
Economic evaluations for the treatment of PrUs using advanced technologies are scarce 
and clinical studies that directly compare two different advanced therapies do not exist.  
Best practice guidelines used clinical research evidence to identify and recommend which 
advanced therapies should be used in the treatment of PrUs.  It is important to not only 
evaluate their clinical effect on healing, but also consider the economic value of these 
therapies.6–8 
41 
 
 
The aim of this study was to estimate the cost effectiveness of two advanced therapies 
using cost utility analysis to calculate outcomes in units that could be compared using 
cost per quality assisted life years (QALY). There are no known studies comparing the 
clinical effectiveness of E-Stim versus NPWT, therefore two decision analytic models 
(DAM) were designed.  The cost effectiveness of E-Stim and NPWT versus SWC for the 
treatment of PrUs from a health care resource perspective was determined.   
3.2 Methods 
The DAMs were constructed using Tree-Age Pro Software Inc, version 2018.  A DAM of 
E-Stim versus SWC was developed based on a previous meta-analysis conducted by Koel 
and Houghton including both published and unpublished data (see Appendix 5).20  An 
extensive literature search did not reveal a meta-analysis on the use of NPWT for the 
treatment of PrUs.  Therefore, the DAM for NPWT versus SWC was based on a 
randomized controlled trial by Ford et al, 2002.21  These studies were chosen since they 
both reported the number of PrU wounds healed.  Demographic characteristics of the 
patient population were not included in the meta-analysis; therefore, the starting mean 
age of 48 was used in the models which was the mean age of participants in the NPWT 
study and ran until age 90.  Both models were run for a cohort of 1000 patients treated 
with each of the wound management regimens considered.  The models assumed that, 
except for the treatment regimen, all other characteristics of the patients treated were 
equal (e.g. wound size, wound duration, and other treatments such as PrU offloading, 
etc.).  The perspective of the study is that of the MOHLTC and no attempt was made to 
capture any indirect costs associated with PrUs.   
In both models, individuals received E-Stim or NPWT versus SWC for six weeks.  SWC 
was defined as the use of basic or advanced wound dressings for local wound 
management.  If the PrU did not heal or patients suffered a recurrence, the patient 
transitioned through various health states using Markov modeling.  Markov models 
predict how a patient or group of patients with a particular condition progress through a 
number of defined health states.15  At the end of a predefined period, individuals can 
remain in one health state or move from one health state to another, according to 
transition probabilities.  Markov models are particularly useful in modeling conditions 
42 
 
 
which can be categorized by a number of discrete health states, and for chronic 
conditions such as PrUs.15  The structure of the Markov model for this study is illustrated 
in Figure 4.   
 
 
 
 
 
  
   
 
 
 
 
 
 
  
 
The health states are intended to reflect separate states that an individual with a PrU may 
experience.   The health states selected in this study were osteomyelitis (OSM), PrU, 
healed or dead.  
Dead and healed states were included as absorbing states meaning that once individuals 
were in the dead or healed states, they could not move out of that state.  The duration of 
each Markov cycle was defined as 3 months which is a suitable length of time for 
individuals to move between each of the health states based on clinical practice.  Data 
utilized to build the model were converted as required using the following equations:   
Pressure 
Ulcer 
Healed 
Dead 
Osteomyelitis 
Figure 4:  Markov 
Model Diagram 
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Rate= -ln (1-p)/t 
Probability=1-exp(-rt) 
Where p=probability, t=time, r=rate 
In some instances, the progression in between disease states was zero if it is not clinically 
feasible.  For instance, individuals with OSM cannot progress directly to a healed state.  
The DAM assumes that individuals would first progress to the PrU state before 
progressing to the healed state.  The model structure allows for the recurrence of a 
pressure injury once healed, and the recurrence of OSM.  The model arms were identical 
for the E-Stim, NPWT and SWC model arms.  An example of one model arm is seen in 
Figure 5.   
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Figure 5:  Decision Analytic Model Arm 
3.2.1 Costs and Resource Use 
Canadian dollars (2017) were used in this analysis and costs were converted using the 
Bank of Canada and Consumer Price Index as appropriate.22,23  One and a half percent 
discounting was applied for the reference model in both analyses and a half cycle 
correction was applied for the Markov models as recommended by the Guidelines for the 
Economic Evaluation of Health Technologies, 2017.24  Only direct medical costs were 
considered in both analyses.  All cost references and data sources are summarized in 
Table 4.   
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Table 4:   Treatment Costs 
Medical Expense Cost 
per day 
Reference  SD Reference Distribution 
E-Stim Equipment 13.35 Houghton et al, 
2010 
6.04 Houghton et al, 
2010 
Gamma 
NPWT Equipment 88.41 Delhougne et al, 
2018 
42.51 Delhougne et 
al, 2018 
Gamma 
SWC 9.58 Houghton et al, 
2010 
4.73 Houghton et al, 
2010 
Gamma 
Interdisciplinary 
Team 
38.32 Research Data, 
2017 
19.00 Research Data, 
2017 
Gamma 
RPN 26.39 www.jobbank.gc.ca 2.64 Assumption Gamma 
Hospitalization 1199.60 OCCI 1911.29 OCCI Gamma 
SD-Standard Deviation; E-Stim-Electrical Stimulation; NPWT-Negative Pressure Wound Therapy; SWC-Standard Wound Care; 
RPN-registered practical nurse; OCCI-Ontario Case Costing Initiative 
 
Patients in the OSM and PrU states were assumed to incur costs related to the treatment 
of their PrU and the healing of the PrU would be by secondary intention.  We did not 
include surgical closure as part of the models since this option is seldom available to 
patients with PrU in this region.    Costs for E-Stim equipment and SWC were referenced 
from the study by Mittmann et al(2011) and converted to 2017 dollars.13  NPWT 
equipment costs were calculated using the data from the study by Delhoughne et 
al(2018), a retrospective cost minimization analysis of disposable and traditional NPWT 
from Medicare claims with costs being converted to 2017 Canadian dollars.25 
Interdisciplinary team costs were derived from data collected as part of the E-Stim 
Collaboration Project which was described above. These costs are outlined in detail in 
Chapter 4.  Registered practice nurse (RPN) costs were calculated using data from the 
Government of Canada job bank website.26  One hour of nursing time costs were 
assumed to be the same as one patient visit for a dressing change.  OSM hospitalization 
costs were calculated using the Ontario Case Costing Initiative (OCCI) data.27  
Multiple assumptions were made to build and compare the two models.  Costs for PrU 
healed were calculated for a six-week time period for each intervention and total cost was 
the cost of the equipment, plus the cost of the interdisciplinary team needed to provide 
optimal wound care.  Markov state costs are reported in Table 5.  For the Markov model 
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OSM state, it was assumed that a patient would be admitted to hospital for 24.8 days over 
the course of one year which is the average length of stay for patients in Ontario with 
pelvic osteomyelitis from OCCI data. 27  When patients in the OSM state were not in 
hospital, they were assumed to receive daily dressing changes from an RPN based on 
current clinical practice.  In the Markov model PrU state, patients were assumed to 
receive daily dressings by an RPN.  In the healed and dead states, costs were assumed to 
be zero.  Initial costs for the OSM and PrU states were calculated for patients receiving  
E-Stim or NPWT based on clinical practice.  Patients who do not heal their PrU after 
receiving six weeks of E-Stim or NPWT were assumed to continue with the advanced 
therapy for an additional three months prior to being discharged from the advanced 
therapy.  For NPWT, it was assumed that if a patient entered the OSM or PrU state, they 
would receive three months of NPWT to manage symptoms of OSM or as a trial period 
for the treatment of the PrU.  If the patient remained in the OSM or PrU state for longer 
than three months, the PrU was assumed to be a non-healing or non-healable.  A non-
healing wound is defined as a wound that has healing potential, but causes and co-factors 
that can interfere with healing have not yet been removed and a non-healable wound is 
defined as a wound where causes and co-factors that can interfere with healing cannot be 
removed, e.g., in cases of terminal disease or end-oflife care.28  Patients with non-healing 
or non-healable wounds receive SWC and are discharged from advanced wound therapies 
due to their low probability that their wound will heal.  For the E-Stim model, it was 
assumed that if a patient had a PrU, they would receive three months of E-Stim as a trial 
period. If the patient remained in the PrU state for longer than three months, the PrU was 
assumed to be a non-healing or non-healable wound and therefore E-Stim would be 
discharged.   
Table 5:  Costs per Three Months Based on a Given State 
State Cost SD Distribution 
cOSM State 10496.75 11858.95 Gamma 
cPrU State 3282.26 431.68 Gamma 
ctransition 3mon NPWT 7426.44 3570.84 Gamma 
ctransition 3mon E-Stim 1926.12 644.42 Gamma 
cOSM-cost osteomyelitis; cPrU-cost pressure ulcer; NPWT-negative pressure wound therapy; E-Stim-electrical stimulation 
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3.2.2 Effectiveness 
The primary outcomes of both analyses were healthcare costs per QALYs gained.  A 
literature review was conducted to select the clinical inputs for the model including 
recurrence rates, rates for progressing to OSM, rates for progressing to death, and utility 
rates.  Search terms were derived to capture information on the effectiveness of E-Stim 
and NPWT. References used in this analysis focused on the clinical effectiveness of 
healing rates for each of the treatment regimens and are summarized in Table 6 and 7.   
Table 6:  Economic Model Clinical Inputs:  E-Stim versus SWC 
Variable Value Unit Reference and 
Year 
Distribution 
PrU healed with E-
Stim 
56.0 % Koel and 
Houghton, 2013 
Beta 
PrU healed with 
SWC  
21.3 % Koel and 
Houghton, 2013 
Beta 
Recurrence 38.0 % Bates-Jensen et 
al, 2009 
Beta 
Develop OSM 24.5 % Darouiche et al, 
1994 
Sugarman et al, 
1983 
Beta 
E-Stim Healed 5.29 QALY Assumption from 
Model 
Gamma 
SWC Healed 5.00 QALY Assumption from 
Model 
Gamma 
PrU-pressure ulcer; E-Stim-electrical stimulation; SWC-standard wound care; OSM-osteomyelitis; QALY-quality adjusted life year 
 
 
 
 
 
 
 
 
 
 
 
 
48 
 
 
Table 7:  Economic Model Clinical Inputs:  NPWT versus SWC 
Variable Value Unit Reference and 
Year 
Distribution 
PrU healed with 
NPWT 
10.0 % Ford et al, 2002 Beta 
PrU healed with 
SWC  
13.0 % Ford et al, 2002 Beta 
Relapse 38.0 % Bates-Jensen et 
al, 2009 
Beta 
Develop OSM 24.5 % Darouiche et al, 
1994 
Sugarman et al, 
1983 
Beta 
NPWT Healed 4.49 QALY Assumption 
from Model 
Gamma 
SWC Healed 4.71 QALY Assumption 
from Model 
Gamma 
PrU-pressure ulcer; NPWT-negative pressure wound therapy; SWC-standard wound care; OSM-osteomyelitis; QALY-quality 
adjusted life year 
Efficacy rates (% of patients with completely healed PrUs) for E-Stim were obtained 
from unpublished meta-analysis data by Koel and Houghton, 2014 that was calculated for 
seven studies with a total of 412 stage III/IV PrUs.20  They found 57.2% of participants 
completely healed with E-Stim versus 21.3% of participants who received SWC.  The 
average duration of E-Stim treatment at 7.25 weeks.  The rate of healing was assumed to 
be the same for six weeks of E-Stim treatment to keep the treatment time prior to entering 
the Markov states similar in the two models.    
Efficacy rates for NWPT were obtained from Ford et al, 2002 who reported 10% of 
participants with PrUs completely healed using NPWT versus 13% of participants with 
PrUs who completed healed using SWC alone over a six-week treatment period.  
Recurrence was defined in the model as recurrence of a PrU after healing.  A value for 
the probability for a recurrence was estimated based on a study by Bates-Jensen et al, 
2009.  The authors reported that 24 out of 64 veterans had a recurrence of a stage III/IV 
pelvic PrU in a nine month follow up period.29  This study was selected given the lack of 
published Canadian PrUs recurrence rates, and it was used in previous economic 
analyses.13  The recurrence rate was assumed to be identical between all treatment arms.  
The prevalence of osteomyelitis for patients with PrUs is between 17%30 to 32%.31  The 
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mean of the studies by Darouiche et al, 1994 and Sugarman et al, 1983 was used in the 
models since these studies continue to be routinely referenced in the current literature as 
the prevalence of OSM for individuals with chronic PrU.   
3.2.3 Transition Rates 
Transition probabilities between each health state and the converted Markov model 
probabilities are shown in Table 8.   The transition probability for the OSM state was 
derived from a study by Bodavula et al, 2015 who performed a retrospective cohort study 
of adult patients with PrUs and pelvic OSM from 2006 to 2011.32  In this study, 120 of 
220 patients diagnosed and treated with OSM were readmitted with OSM equating to a 
probability of 54.5% recurrence over six years.  The transition probability of PrU to Dead 
was referenced from the article by Lynder et al, 2012, who completed a retrospective 
analysis of hospital-acquired PrUs and reported on the risk of mortality with PrUs within 
30-days of being discharged from the hospital.33  OSM to Dead transition probabilities 
were derived from the study by Huang et al, 2016 who evaluated the risk of mortality in 
the elderly who have been diagnosed with chronic OSM.34  The transition probabilities of 
PrU to healed was obtained from the Koel and Houghton, 2014 and Ford et al, 2002 
studies for the applicable DAM.20,21   
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Table 8:  Yearly Transition Probabilities in Both Models 
Variable % Reference Distribution 
pOSM to Death                
Age    70 
0.7 Huang et al, 2016 Beta 
                                            
80 
1.1   
>85 1.4   
pPrU to Death 2.0 Lynder et al, 2012 Beta 
pOSM stay OSM 4.2 Bodavula et al, 2015 Beta 
pPrU to Healed E-
Stim 
84.0 Houghton et al, 
2010 
 
Beta 
pPrU to Healed 
SWC 
40.5 Houghton et al, 
2010 
 
Beta 
pPrU to Healed 
NPWT 
20.3 Ford et al, 2002 Beta 
pPrU to Healed 
SWC 
26.1 Ford et al, 2002 Beta 
pOSM-probability of osteomyelitis ; pPrU-probability of pressure ulcer ; E-Stim-electrical stimulation ; SWC-standard wound 
care ; NPWT-negative pressure wound therapy ; SWC-standard wound care 
 
3.2.4 Utility Values 
Utility values for individuals in the community with PrUs have not been published.  
However, Thein et al, 2009 evaluated the health status utilities in long-term care residents 
in Ontario both with and without PrU on health-related quality of life (HRQOL).35  Essex 
et al, 2009 studied the impact of pressure ulceration on health-related quality of life for 
hospital inpatients in the United Kingdom.36  The mean utility scores of these two studies 
were used in the models and assumed to be similar to the community PrU population and 
shown in Table 9.  QALYs in the healed terminal mode in the decision tree were assumed 
to be the same as the QALYs for the healed absorbing state in the Markov model.     
Table 9:  Utility Values 
EQ-5D Index 
Scores 
With PrU Without PrU Reference Distribution 
Markov Model 0.225 (0.35) 0.42 (0.36) Thein et al, 
2009 
Essex et al, 
2009 
Beta 
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3.2.5 Cost-Effectiveness Analysis 
The cost-effectiveness of managing patients with an advanced therapy compared with 
SWC alone was calculated as the difference between the expected costs of the two 
strategies divided by the difference between the expected outcomes between the two 
strategies.  The relative cost effectiveness of E-Stim and NPWT was defined as the cost 
per QALY gained.  If a treatment resulted in an improved outcome for less cost, it was 
defined as a “dominant treatment”.  A treatment is considered dominant when one 
treatment has a higher effectiveness and lower cost than its comparator.15   The 
willingness to pay (WTP) values a health gain in terms of the amount a person is willing 
to pay to obtain the health gain.37 The WTP threshold chosen for this analysis was 
$50,000 per QALY which is frequently referenced in the literature.38 
3.2.6 Sensitivity Analyses 
Deterministic sensitivity analyses (DSA) were performed to identify how the cost per 
QALY gained with using E-Stim or NPWT would change by varying different individual 
parameters in the models.  For the E-Stim versus SWC model, cost for E-Stim was 
increased, probability of PrU healing was decreased, and probabilities of recurrence rates 
were decreased by a rate of 25%.   For the NPWT versus SWC model, costs for SWC 
were increased, probability of healing was decreased, and probabilities of recurrence 
rates were decreased also by a rate of 25%.   
Probabilistic sensitivity analyses (PSA) were undertaken to assess uncertainty in the 
model inputs using Monte Carlo simulations (1000 iterations of the model) by 
simultaneously varying the probabilities, unit costs, resource use values and utilities 
within the model.  Probabilities were varied according to a beta distribution using 
expected values of population size and occurrences, utilities were varied according to a 
beta distribution using means and standard deviations.  Costs were varied randomly, 
according to a gamma distribution using means and standard deviations.   
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3.3 Results 
3.3.1 E-Stim versus SWC 
Patients who receive E-Stim for the treatment of PrUs benefit from an additional 0.2 
QALYs at an incremental cost of $3675.82 less than SWC (Table 10).  The cost analysis 
determined that E-Stim is dominant over SWC since E-Stim treatment is less costly but 
more effective in comparison to SWC.  The cost for treating a patient with a PrU using 
SWC alone was $7976.02 with an effectiveness of 5.14 QALYs.  The cost for treating a 
patient with a PrU using E-Stim was $4300.20 with an effectiveness of 5.34 QALYs (as 
shown in Figure 6).  The Markov model predicted that 96.8% individuals with a PrU 
receiving E-Stim would be healed compared to 80.9% of individuals receiving SWC 
alone after one year (Table 11).    
Table 10:  ICER Value E-Stim versus SWC 
 Cost Incremental 
Costs 
Effectiveness ICER 
SWC 7976.02 3675.82 5.14 dominated 
E-Stim 4300.20  5.34  
Table 11:  Number of Patients in Each Health State after 1 year in the Markov 
Model for a Cohort of 1000 Patients (%) 
 OSM PrU Healed Dead 
E-Stim versus SWC model 
E-Stim 0 0 96.8 2.5 
SWC 1.0 13.8 80.9 4.2 
NPWT versus SWC model 
NPWT 2.2 38.5 53.8 5.5 
SWC 1.8 29.4 63.7 5.1 
OSM-Osteomyelitis; PrU-Pressure Ulcer; E-Stim-electrical stimulation; SWC-standard wound care; NPWT-negative pressure wound 
therapy  
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Figure 6:  Cost-Effectiveness of E-Stim versus SWC 
Using DSA for multiple parameters, E-Stim continued to be dominant versus SWC 
(Figures 7-9).  In the PSA, 65.3% of the total iterations resulted in Incremental Cost 
Effectiveness Ratios (ICERs) that were economically dominant for E-Stim and an 
additional 31.0% of iterations were below the WTP threshold which is most commonly 
set at $50,000.  Thirty-eight percent of iterations were greater than the $50,000 per 
QALY threshold (Table 12).  A visual representation of the probabilistic sensitivity 
analysis is shown using an ICER Scatterplot (Figure 10).  Scatterplots are useful to 
visually demonstrate the amount of uncertainty by plotting the data into quadrants.  In the 
E-Stim versus SWC scatterplot, most data points fall in Quadrant 1 showing that E-Stim 
is dominant over SWC.  All points fall below the $0.00 line showing that E-Stim is 
always less costly than SWC.   
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Table 12:  ICER Report E-Stim versus SWC 
COMPONEN
T 
QUADRAN
T 
ICER FREQUENC
Y 
PROPORTIO
N 
C1 IV Superior 652 0.652 
C2 I ICER<50000.
0 
0 0 
C3 III ICER>50000.
0 
38 0.038 
C4 I ICER>50000.
0 
0 0 
C5 III ICER<50000.
0 
310 0.31 
C6 II Inferior 0 0 
Indifferent origin 0/0 0 0 
ICER-Incremental Cost Effectiveness Ratio; E-Stim- electrical stimulation; SWC- standard wound care 
 
Figure 7:  Pressure Ulcers Healed with Electrical Stimulation Treatment Decreased 
by 25% 
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Figure 8:  Electrical Stimulation Cost Increased by 25% 
 
Figure 9:  Pressure Ulcer Recurrence Rate Decreased by 25% 
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Figure 10: Incremental Cost-Effectiveness Ratio Scatterplot:  Electrical Stimulation 
(E-Stim) versus Standard Wound Care (SWC) 
3.3.2 NPWT versus SWC 
Patients who receive NPWT for the treatment of PrUs decreased 0.14 QALYs at an 
incremental cost of $7041.56 for NPWT over SWC resulting in SWC being the dominant 
intervention for the treatment of PrUs in the second model (Table 13).  The cost for 
treating a patient with a PrU using SWC was $12,379.69 with an effectiveness of 4.94 
QALYs.  As shown in figure 11, the cost for treating a patient with a PrU using NPWT 
was higher than SWC ($19,421.25) and the  QALYs was lower (4.80).  For individuals 
that did not heal within the six-week period and have a PrU or recurrence, the Markov 
model predicted that 53.8% of PrUs would be healed using NPWT compared to 63.7% of 
individuals receiving SWC alone after one year (Table 11). 
 
Table 13:  ICER Value NPWT versus SWC 
 Cost Incremental 
Costs 
Effectiveness ICER 
SWC 12379.69  4.94  
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NPWT 19421.25 7041.56 4.80 dominated 
ICER- Incremental cost effectiveness ratio; NPWT-negative pressure wound therapy; SWC- standard wound care 
 
 
Figure 11:  Cost-Effectiveness of NPWT versus SWC 
Using the deterministic sensitivity analysis for multiple parameters, SWC continued to be 
dominant versus NPWT (Figures 12-14).  In the probabilistic sensitivity analysis, 44.9% 
of the total iterations resulted in ICERs where NPWT was costlier than SWC but below 
the WTP threshold, 5% of the total iterations where NPWT was less costly than SWC but 
above the WTP threshold, and 24.5% of the total iterations resulted in ICERs that were 
economically inferior for NPWT (Table 14).  The ICER Scatterplot for NPWT versus 
SWC is shown in Figure 15.  Most of the data points fall into quadrants 2, 4, and 6 above 
the $0 line indicating SWC is less costly than NPWT in most instances. 
Table 14: ICER Report NPWT versus SWC 
COMPONEN
T 
QUADRAN
T 
ICER FREQUENC
Y 
PROPORTIO
N 
C1 IV Superior 9 0.009 
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C2 I ICER<50000.
0 
449 0.449 
C3 III ICER>50000.
0 
1 0.001 
C4 I ICER>50000.
0 
291 0.291 
C5 III ICER<50000.
0 
5 0.005 
C6 II Inferior 245 0.245 
Indifferent origin 0/0 0 0 
ICER-incremental cost effectiveness ratio; NPWT-negative pressure wound therapy; SWC-standard wound care 
 
 
 
Figure 12:  Pressure Ulcers Healed with Standard Wound Care Decreased by 25%  
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Figure 133: Standard Wound Care Costs Increased by 25%  
 
Figure 144:  Pressure Ulcer Recurrence Rate Decreased by 25% 
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Figure 15: Incremental Cost Effectiveness Ratio:  Scatterplot Negative Pressure 
Wound Therapy (NPWT) versus Standard Wound Care (SWC) 
3.4 Discussion 
Using the decision analytic framework for E-Stim versus SWC, the use of E-Stim for the 
treatment of PrUs was dominant over SWC.  By contrast, in the decision analysis that 
compared NPWT to SWC, the use of SWC for the treatment of PrUs was dominant over 
NPWT.  The analysis of the two models demonstrates that from a cost-utility perspective, 
E-Stim is the most cost-effective treatment for the healing of PrUs.  This finding is 
supported by treatment recommendations made in multiple best practice guidelines.6–8 
The results from this study are based on a DAM that combines a decision tree with a 
Markov model, which is a new approach to estimate and compare the cost for two 
treatment interventions for PrUs.  This approach was used since it most closely mimics 
clinical pathways for individuals with PrUs receiving treatment in home and community 
care (HCC).  Patients who are diagnosed with PrUs are provided SWC and advanced 
therapies such as E-Stim or NPWT.  The decision as to which treatment they receive is 
determined by the physician or nursing health care provider in the home.  Patients that 
progress to healing utilizing the initial treatment intervention are discharged from HCC 
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services.  Patients who do not heal their PrU or have a recurrence of their PrU, progress 
to the chronic disease states of OSM or PrU and continue to require HCC.  Our model 
allowed for patients to follow the decision tree arm for six weeks, and if not healed, a 
Markov model was applied for the chronic states.   
This paper was also unique in its use of two models in order have a common parameter of 
QALYs to compare two PrUs advanced treatments.  There are no known research papers 
that directly compare E-Stim to NPWT and therefore each was analyzed separately using 
SWC as the comparator.  The evidence for the use of E-Stim for the treatment of PrU was 
taken from a meta-analysis because it is the highest level of evidence and therefore 
considered to be the most accurate in its ability to determine the number of PrUs healed 
with use of E-Stim versus SWC.20  For the NPWT analysis, no meta-analysis that 
compared NPWT to SWC using number of healed PrU was available.  Therefore, a 
randomized controlled trial (RCT) was used.21  With both therapies, the highest level of 
available evidence was chosen.   
In order to assess for the variables of number of PrUs healed, length of time to PrU 
healing, and recurrence rates, sensitivity analysis was conducted for both models using 
one-way sensitivity analysis of 25%.  After sensitivity analysis the results remained 
similar for the E-Stim versus SWC and NPWT versus SWC. Specifically, E-Stim 
remained dominant over SWC, and SWC remained dominant over NPWT in all the 
explored scenarios. 
The results from the DAM for E-Stim versus SWC showed that after one year, 
individuals receiving E-Stim for the treatment of PrU’s would be healed in 96.8% of 
cases versus 80.9% of cases treated with only SWC.  These estimates are significantly 
higher than the estimates found in the study by Mittmann et al, 2011 who reported that 
after 1 year of treatment with E-Stim, an average of 20.8% of individuals with a PrU 
would be healed compared to an average of 4.5% of individuals receiving SWC alone.  
We used healing rate probabilities for E-Stim and SWC which were much higher than the 
RCT data used to build the model in the study by Mittmann et al.   
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The cost for the predication of healing with the use of E-Stim over six weeks was found 
to be $2572.50.  The results are similar to a recently published Ontario Health 
Technology Advisory Committee (OHTAC) analysis which reported that when E-Stim 
was administered by a health care professional for the treatment of PrU, cost per patient 
ranged from $712 in long-term care to $2,572 in home care. When administered by a 
patient or caregiver, cost per patient was $179.00 CDN (2017).39  OHTAC predicted the 
need for $0.77 to 3.85 Million yearly costs to implement E-Stim for the treatment of PrUs 
in Ontario.  Contrary to the results in the OHTAC review, we found that the addition of 
E-Stim for the treatment of PrUs is cost effective given it is dominant over SWC.   
The cost for the healing of PrU in six weeks with NPWT was estimated to be $5322.66 
which is comparable to the average cost to heal multiple types of wounds using NPWT of 
$4650.00 US reported by Delhougne et al, 2018.25 We attempted to use the costing data 
and QALY data to determine cost per QALYs gained for the use of NPWT as an advance 
treatment versus SWC since this has not been previously reported in the literature.  Due 
to SWC being a dominant treatment in comparison to NPWT, we were unable to report 
on cost per QALYs gained.  These findings contrast with previous cost studies which 
showed NPWT was a cost-effective treatment for PrUs.16–18   
This research uses a novel approach by linking a decision tree and Markov model for cost 
analysis of two advanced therapies for PrU treatment.  Using this decision analytic 
model, cost analysis was able to closely mimic outcomes that are based on clinical 
practice.  This approach for the costing of wound care treatment also can also allow for 
the evaluation of healing, non-healing and non-healable wounds in the same model which 
may be useful in future research.    
3.5 Conclusion 
From an Ontario health system perspective, the use of E-Stim for the treatment of PrU’s 
is a cost-effective intervention whereas using NPWT to treat PrU’s is not cost-effective 
when compared to standard wound care practices without an advanced therapy. This 
study supports the need for increased knowledge translation for the use of E-Stim in the 
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treatment of PrUs as an intervention that supports best practice and cost effectiveness in 
this patient population.   
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4 Cost of Pressure Ulcer Care for Individuals Living in the 
Community with a Mobility Impairment 
4.1 Introduction 
Pressure ulcers (PrUs) are a common complication occurring across all sectors of health 
care including hospitals, long term care, and home and community care.1–3  A PrU is a 
localized injury to the skin and/or underlying tissue usually over a bony prominence, as a 
result of pressure, or pressure in combination with shear.4  The severity of PrUs has been 
described by the National Pressure Ulcer Advisory Panel’s Staging system, with a Stage 
IV PrU representing a more severe and deeper wound.4  PrUs often occur in those with 
mobility impairment and are a common secondary health complication for individuals 
with spinal cord injury (SCI).5,6  PrUs result in a decreased quality of life7–9 and increased 
mortality rates.10–12  PrUs also cause a large financial burden to the health care system.   
Bennett et al, 2004 evaluated the cost of patients in a hospital or long term care setting in 
the United Kingdom and found the mean cost of healing a single stage III PrU was 
7,313£ and rose to 10,551£ if the patient had a Stage IV PrU.13   Brem et al, 2010 also 
evaluated the cost of PrUs in a hospital setting by conducting a retrospective chart review 
of 19 patients with PrUs who were admitted over a 29 month period to a university based, 
tertiary-care hospital in the USA.14  The total hospital costs for a community-acquired 
PrU was $124,327US.   Chan et al, 2013 conducted a similar study while patients with 
PrUs were admitted to acute care hospitals in Canada.15  Specifically, they used an 
administrative database called the Ontario Case Costing Initiative (OCCI) to evaluate the 
net cost of PrUs that were either present prior to admission or occurred during admission 
to acute hospitals.  Over a 5-year period (2002-2006), 1351 with hospital acquired PrUs 
and 2524 people with community acquired PrUs were identified and compared to a 
similar matched group of elderly patients (>65years of age) without PrUs.  The total net 
adjusted hospitalization cost of treating someone with a stage II – IV PrU ranged between 
$11,000 and $90,000 CDN with higher costs for people with more severe PrUs (stage IV) 
and with hospital acquired ulcers.  These results provide estimates of the additional costs 
incurred by hospitals for patients with PrUs, however, this does not provide a value for 
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the total cost of a PrU to other parts of the Canadian health care system and to society in 
general.    
Costs of living in the community with a PrU have been explored as part of a pragmatic 
clinical research trial conducted in a small urban center in Ontario, Canada.16  Health care 
costs associated with community based PrU care was gathered for 12 community 
dwelling individuals living with SCI and PrUs who were followed for a 7-month period.  
Using unit costs from publicly available sources, they estimated an average incremental 
cost of $4745 +/- 9270 per month in 2011 Canadian dollars.  Values per patient were 
markedly different depending on whether they required emergency room visits (5 
patients) or hospital admissions (2 patients).  However, these cost estimates did not 
include any out-of-pocket expenses or costs associated with wound care equipment or 
supply costs.   A case study published by Allen and Houghton in 2004, estimated the cost 
of treating a stage III PrU in the community was $9000 per month Canadian dollars.  This 
case did include lost wages, wound care supplies and equipment rental costs.17      
There is very limited information about the cost of treating chronic PrUs occurring in 
people living in the community.  Most cost estimates published to date use administrative 
databases and aggregate data rather than patient level data that is collected prospectively 
to identify the number or type of resources used.  The objective of this study was to 
determine the cost of PrU care in a representative sample of individuals living in the 
community with a mobility impairment.  We used cost diaries to follow patients who had 
been living with a chronic PrU allowing for a cost estimate of “real life” practice.  Costs 
were evaluated from a ministry of health and long-term care (MOHLTC) and societal 
perspective.    
4.2 Methods 
4.2.1 Population 
The population cohort was obtained as part of a multi-year knowledge mobilization 
project called the E-Stim Collaboration Project aimed to promote the uptake of best 
practices related to PrU care including the use of an advanced therapy called E-Stim.   
Participants were identified with mobility impairment including SCI who lived in the 
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community, had an open PrU (>1cm2), and were receiving publicly funded home care 
services.  Within this region, health care is coordinated by the South West Local Health 
Integrated Network (South West LHIN) which is funded by the MOHLTC.   The South 
West LHIN provides home care services by contracting several provider agencies that 
employ nurses, allied health professionals, as well as unregulated support workers.  
Ethics approval was obtained from the Western University Health Science Research 
Ethics Board (REB # 106157), the Lawson Health Research Institute Research Ethics 
Board, and the Ethics Committee of participating agencies (see Appendix 3 and 4).   
4.2.2 Resource Utilization 
Participants who signed a written consent form underwent an in-home initial 
comprehensive PrU assessment which included a cost diary.  All cost diary data was 
collected in person with participants  conducted by the same lead author.  Costs were 
analyzed from a MOHLTC and societal perspective including government assistance, 
patients and informal caregivers.  Participants were instructed to answer cost diary 
questions based on recall for the six-month period prior to the initial assessment.   They 
were also asked to indicate if they felt the costs they identified were related to their PrU.  
The following resources were collected (i) emergency room (ER) visits, (ii) inpatient 
hospitalization stays, (iii) family physician visits, (iv) physician specialist visits, (v) clinic 
visits, (vi) private pay nursing and allied health practitioner visits, (vii) laboratory tests, 
(viii) diagnostic imaging, (ix) medications, (x) paid employment time lost, (xi) 
homemaking or volunteer time lost, (xii) assistance with daily activities time (xiii) and 
cost of items purchased for pressure injury management.  Home and community care 
(HCC) costs were provided for each enrolled participant using South West LHIN case 
costing database.  HCC utilization included the costs of publicly funded wound care 
supplies and equipment, and the number of home visits by various health care providers 
(nursing, enterostomal therapy (ET), physiotherapy, occupational therapy, registered 
dietitian and personal support workers).   
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4.2.3 Costs 
Sources used to estimate the cost of each item identified by the participants are 
summarized in Table 15.  Costs for services provided by the publicly funded home and 
community care (HCC) were provided by the South West LHIN.  Costs for physician 
visits, laboratory tests and medical procedures were obtained from the Ontario MOHLTC 
Schedule of Benefits, 2015.18  Hospital costs were obtained from the OCCI.(19)  ER visit 
costs were based on the results by Zoutman et al, 1998 with costs inflated to 2017 
dollars.19  These values were also used in the study by Chan et al, 2012 to assess ER visit 
costs.  Average hourly wages for personal assistance and homemaking was obtained from 
the Human Resources and Skills Development Canada.20  Unit costs for medications 
were obtained from the Ontario Drug Benefit Formulary. Equipment costs were specific 
to out of pocket expenses paid by the participant related to their PrU.    
Table 15:  Unit Costs and Reference 
Unit Costs 
Variable  Unit Cost  Definition References 
Health Care Professionals 
   
Per visit 
   
Family Physician  $                          38.35 Code A004 (1) 
Plastic Surgeon  $                          81.10  Code A085 (1) 
Cardiologist  $                        157.00  Code A605 (1) 
Physiatrist  $                          39.00  Code H312 (1) 
Otolaryngologist  $                          77.90  Code A245 (1) 
Infectious Disease Specialist  $                        157.00  Code A465 (1) 
Wound Specialists  $                          38.35  Code A004 (1) 
Urologist  $                          80.00  Code A355 (1) 
Vascular Surgeon  $                          90.30  Code A175 (1) 
General Surgeon  $                          90.30  Code A035 (1) 
General emergency visit  $                          76.90  Code A100 (1) 
Radiologist  $                          50.00  Code A335 (1) 
Orthopedic Surgeon  $                          83.10  Code A065 (1) 
Haematology  $                        157.00  Code A615 (1) 
Ophthalmology  $                          82.30  Code A235 (1) 
Medical Oncology  $                        157.00  Code A445 (1) 
Psychiatry  $                        199.40  Code A195 (1) 
Gastrologist  $                        157.00  Code A415 (1) 
Per hour 
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Average Salary in Ontario  $                          26.08  
 
(2) 
Private Pay Services 
   
Naturopath  $                     1,200.00  Over 6 months period Patient report 
RMT  $                          60.00  cost per visit Patient report 
Emergency Room 
   
ER visit per hour  $                        358.93   (3) 
Hospitalization (per day) 
 
 
 
Pressure Injury infection  $                     1,030.60  OCCI code L893 (4) 
AAA repair  $                     4,020.00  OCCI code I714 (4) 
Urinary Tract Infection  $                        924.41  OCCI code N390 (4) 
Dehydration  $                        885.91  OCCI code E860 (4) 
Bowel Obstruction  $                     1,290.85  OCCI code K565 (4) 
ALC bed  $                        842.00  CIHI code Z59 (5) 
Clinic Visits 
   
Pain clinic  $                          38.35  Code A004 (1) 
Wound clinic  $                          38.35  Code A004 (1) 
Walk in clinic  $                          38.35  Code A004 (1) 
Laboratory test and DI (per test) 
  
CBC  $                          16.00  Code L393 (6) 
X-ray hip  $                          31.40  Code X060 (1) 
X-ray chest  $                          32.65  Code X091 (1) 
X-ray leg  $                          21.30  Code X063 (1) 
CT scan hip  $                          43.25  Code X412 (1) 
ECG  $                          11.05  Code G310, G313 (1) 
Urine Culture  $                            7.00  Code L641 (6) 
Wound Swab  $                          25.00  Code L628 (6) 
PICC line  $                        168.00  Code Z456 (1) 
MRI  $                          48.35  Code J163 (1) 
Medications 
   
hydromorph contin  $                             0.97  4.5mg Cap (7) 
fentanyl  $                             3.66  25mcg/hr Trans Patch (7) 
percocet  $                             0.13  5mg/325mg Tab (7) 
oxyNEO  $                             0.18  5mg Tab (7) 
oxybutynin  $                             0.10  5mg Tab (7) 
zopiclone  $                             0.22  5mg Tab (7) 
lorazepam  $                             0.07  2mg Tab (7) 
haldol  $                             0.44  5mg Tab (7) 
gabapentin  $                             0.04  100mg Cap (7) 
amitriptyline  $                             0.15 50mg Tab (7) 
baclofen  $                             0.31  20mg Tab (7) 
ratio-Lenoltec  $                             0.05  300mg & 15 mg & 15 mg (7) 
tylenol  $                             0.03  500mg (7) 
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co-citalopram  $                             0.13  20mg Tab (7) 
paroxetine  $                             0.33  20mg Tab (7) 
cymbalta  $                             0.48  300mg Cap (7) 
escitalopram  $                             0.33  20mg Tab (7) 
quetiapine  $                             0.78  150mg Tab (7) 
novo mirtazapine  $                             0.10  15mg Tab (7) 
levofloxacin  $                             1.37  500mg Tab (7) 
ciprofloxacin  $                             0.50  500mg Tab (7) 
xarelto  $                             2.87  20mg Tab (7) 
ferrous gluconate  $                             0.04  300mg (7) 
actonel  $                          11.66 35mg (7) 
cholecalciferol  $                             2.43  70mg Tab (7) 
docusate sodium  $                             0.03  100mg Cap (7) 
levothyroxine  $                             0.90  0.025mg (7) 
metoprolol  $                             0.06  50mg Tab (7) 
nabilone  $                             6.78  1mg (7) 
oxybutynin  $                             0.97  5mg Tab (7) 
warfarin  $                             0.67  2.5mg Tab (7) 
senokot  $                             0.03  8.6mg Tab (7) 
risedronate  $                          11.19  150mg Tab (7) 
biscodyl  $                             0.05  5mg Tab (7) 
salbutamol  $                             5.00  100mcg (7) 
colace  $                             0.13  100mg Cap (7) 
fumarate  $                             0.11  300mg Cap (7) 
lactulose  $                             0.01  30mLs (7) 
olanzapine  $                             7.56  20mg Tab (7) 
atorvastatin  $                             0.80  40mg Tab (7) 
furosemide  $                             0.04  20mg Tab (7) 
enablex  $                             1.61  7.5mg Tab (7) 
dutasteride  $                             0.30  20mg Tab (7) 
pantoloc  $                             2.08  40mg (7) 
diltiazen  $                             0.48  180mg Tab (7) 
eliquis  $                             1.63  5mg (7) 
toloxin  $                             0.21  0.125mg Tab (7) 
celebrex  $                             0.26  200mg Cap (7) 
lansoprazole  $                             0.50  30 mg Cap (7) 
rabeprazole  $                             0.13  20mg Tab (7) 
methotrexate  $                             0.63  2.5mg Tab (7) 
amlodipine  $                             0.13  5mg Tab (7) 
atorvastatin  $                             0.80  10mg Tab (7) 
midodrine  $                             0.44  2.5mg Tab (7) 
75 
 
 
morphine  $                             2.09  15mg Tab (7) 
nitrofurontoin  $                             0.23  100mg (7) 
venlafaxine  $                             0.12  75 mg Cap (7) 
ranitidine  $                             0.12  150mg Tab (7) 
gliclazide  $                             0.06  60mg Tab (7) 
hydrochlorothiazide  $                             0.02  12.5mg Tab (7) 
rosuvastatin  $                             0.14  10mg Tab (7) 
metformin  $                             0.43  500mg Tab (7) 
losartan  $                             0.31  100mg Tab (7) 
sulfatrim  $                             0.15  800mg (7) 
 
4.3 Analysis 
HCC costs were provided for 11 participants from South West LHIN case costing 
database.  For the participants who did not have administrative data provided, the mean 
cost for HCC purchased services and purchased items calculated for 11 participants was 
used.  The cost of zero ($0.00) was used when a participant did not report utilization of a 
resource in the cost diary.  All cost diary items were entered into a Microsoft® Excel 
spreadsheet and average monthly costs per participant were calculated by summing the 
total costs over six months for each participant.  The overall cost per patient per month 
for the 22 participants was calculated using the mean monthly cost for each participant.   
Average costs were also calculated based on costs identified as PrU specific and type of 
mobility impairment.   Sensitivity analysis was conducted on costs subject to variability.  
This included HCC costs, hospitalization costs, and purchased equipment costs.   
4.4 Results 
Twenty-two participants were included in the study (see Table 16).  The average age was 
58.5 years (+/-15.5) and 68.2% (15/22) were male.  Eighty-two percent of were 
individuals who had a SCI for an average of 13.8 (+/-11.5) years, with majority (55%) 
having only lower extremity involvement (paraplegia).  Four people had mobility 
restrictions due to other neurological conditions including stroke, Parkinson’s disease, 
depression and a below knee amputation.  Mean wound duration for the cohort was 21.2 
(+/-24.2) months with a mean surface area of 6.6 (7.6) cm2.  PrU location included ischial 
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tuberosity (50%), coccyx (18.2%), sacrum (13.6%), foot/heel (9.1%), leg from prosthesis 
pressure (4.5%) and shoulder (4.5%).  Participants had PrUs that were primarily stage III 
(40.9%) and IV (50%), one participant was diagnosed with a deep tissue injury, and one 
participant had eschar overlying the wound making the wound unstageable.    
Table 16:  Demographics 
Age Mean (SD) 58.4(15.5) 
Male/Female (%)  Male: 68.2; Female: 31.8 
Injury (%) 
• Upper SCI (cervical spine injury) 27.0 
• Lower SCI 55.0 
• Catatonic Depression 4.5 
• Below Knee Amputation 4.5 
• Cerebrovascular Accident 4.5 
• Parkinson’s Disease 4.5 
Years with SCI Mean (SD); n=18 13.8 (11.5) 
Months with PrU Mean (SD) 21.2(24.2) 
Wound Surface Area in cm2 Mean (SD) 6.6(7.6) 
Wound Site (%) 
• Ischial Tuberosity (n=11) 50.0 
• Coccyx (n=4) 18.2 
• Buttock (n=3) 13.6 
• Other (n=4) 18.2 
Stage of PI (%) 
• Unstageable (n=1) 4.5 
• Deep Tissue Injury (n=1) 4.5 
• Stage III (n=9) 40.9 
• Stage IV (n=11) 50.0 
 
 
Total average monthly costs for a person with limited mobility living in the community 
with a PrU were estimated to be $8,247.48 (+/-16,549.35) in 2017 Canadian dollars.   
Percentage of monthly costs for each cost diary item is shown in Figure 16.   
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HCC-home and community care; ER- emergency room; HCP- health care provider; FP-family physician; HK-housekeeping  
Figure 166:  Percentage of Average Monthly Costs 
 
Hospitalization costs accounted for 64% of total costs with seven of the 22 study 
participants’ having been hospitalized within six months prior to completing the cost 
diary.  All study participants received HCC services which accounted for 24% of total 
costs.  Eleven participants reported at least one visit to the ER, 17 participants went to 
their family doctor, 15 participants attended at least one specialist physician visit, and 
four participants reported having been to a medical clinic.  Sixteen participants reported 
having had a laboratory test or underwent diagnostic imaging in the previous six months, 
and only three participants did not report any prescribed medications, however, all 
participants reported they paid out of pocket for supplements such as vitamins that were 
recommended to help manage their PrU.  Ten participants recalled additional costs paid 
for expenses such as transportation or parking in order to attend medical appointments.  
Three participants paid out of pocket for private healthcare services including naturopath, 
personal support worker and physiotherapist not funded by the MOHLTC. Fourteen 
participants reported on out of pocket expenses they paid for equipment such as 
wheelchairs, specialized mattresses, dressings, and supplements. Five participants 
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reported homemaking, caregiving, or volunteer time lost due to their PrU.  Two of the 22 
participants were working at the time of the assessment, however only one participant 
reported wages lost due to their PrU.   
Average cost per month per person was calculated from MOHLTC, social assistance and 
out of pocket costs for the patient (see Table 17).  Average cost per month per person 
with tetraplegia was $10,122.22, with paraplegia was $9,106.06 and with other mobility 
impairment was $2,859.62.  Cost per month per person when costs were specifically 
identified by participants for treatment of their PrU was $3107.73.  The average cost of 
equipment purchased to manage pressure was $5,584.45 per person.   
Table 17:  Average Costs per Patient Per Month 
Average Costs of Individuals with Mobility Impairment and Pressure Ulcers (N=22) 
 Average Cost per 
month per person  
(Range) 
Ministry of Health and Long-Term Care Costs 
HCC Purchased Services $1478.55  ($402.27-4,155.00) 
HCC Purchased Items $506.40  ($157.00-1,807.00) 
Emergency Room Visits $43.51  ($0-59.82) 
Hospital Admissions $5,173.88  ($0-75,040.00) 
Family Physician Visits $9.88  ($0-25.57) 
Specialist Visits $23.04  ($0-107.70) 
Clinic Visits $3.78  ($0-38.35) 
Tests and Lab $8.93  ($0-44.93) 
Government Subsidized Costs 
Medications $236.46  ($0-1,384.84) 
Patient “out of pocket” Costs 
Additional Costs $1.15  ($0-8.33) 
Health Care Providers-Private Pay $367.27  ($0-3,040.00) 
Lost Wages $23.71  ($0-521.60) 
Homemaking Time Lost $370.93  ($0-3,129.60) 
TOTAL COSTS $8247.49 $559.27-89,362.74 
 
 
Table 18 shows the effects of the sensitivity analysis on average monthly costs. Costs 
remained relatively similar when there were no costs assumed for unpaid time lost for 
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homemaking, volunteering and caregiving.   Monthly costs decreased when no cost for 
alternative level of care beds was assumed, no cost for private health care providers was 
assumed, and the lowest monthly cost for HCC was used.  Monthly costs increased when 
it was assumed that the reported equipment was purchased by participants within the last 
six months and when the maximum monthly cost for HCC was used. 
Table 18:  Average Monthly Costs with Sensitivity Analysis 
Variable Changed Average Cost per month per person (SD) 
No costs for unpaid time lost for 
homemaking, volunteering and primary 
caregiver 
$8,054.37 ($16,619.16) 
Equipment purchased assumed to be within 
the last 6 months 
$9,178.22 ($16,368.19) 
No cost for Alternate Level of Care beds  $7,086.54 ($16,002.06) 
No cost for private Health Care Providers $7,880.21 ($16,624.48) 
Minimum HCC costs $6,996.62 ($16,452.61) 
Maximum HCC costs $11,510.53($16,452.61) 
 
Visits by different health care providers within the HCC system are shown in Table 19.  
The median number of HCC nursing visits was 17 per patient per month (range 5-34).   
The median monthly visit rate  ET visits was one, zero for physiotherapy, one for 
occupational therapy, and zero for registered dietitian.    
Table 19:  Home and Community Care Service Utilization per Participant per 
Month 
 Visiting 
Nurse 
Enterostomal 
Therapist 
Physiotherapist Occupational 
Therapist 
Registered 
Dietitian 
Median 17 1 0 1 0 
Range 5-34 0-2 0-3 0-4 0-2 
 
4.5 Discussion 
The results of this study have demonstrated that each individual who has a mobility 
impairment resulting in a PrU has an estimated monthly cost of over $8200.00 Canadian 
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dollars.  For our cohort of 22 patients, whose average wound duration was 21.2 months, 
this would result in a total cost of $3,846,624.50 spent at the time of initial assessment.   
To our knowledge, this is the first prospective study that used patient level data to 
estimate the cost of living in the community with a PrU from a MOHLTC and societal 
perspective. In an economic evaluation completed for the Spinal Cord Injury Research 
Evidence (SCIRE) evaluating health care resources, the total mean annual cost per 
individual with SCI in Ontario is approximately $180,000.16  Our estimate of annual costs 
for health care treatments of the SCI group of participants in the present study was 
similar at $144,747.54.  It is well known that PrUs are often a secondary complication of 
chronic disease, and consequently all health comorbidities impact an individual’s ability 
to heal their PrU.  Therefore, it is challenging to estimate costs specifically associated 
with a comorbidity such as PrUs.     In this study, we choose to let participants designate 
which costs were directly associated with their PrU.  This yielded an average annual cost 
of $38,111.88 per person.  In addition, when we asked them to estimate out of pocket 
expenses for pressure redistribution equipment that they were currently using, an 
additional cost of $5,584.45 per person was calculated.     
In our study, hospitalization costs accounted for 64% of total monthly costs with seven of 
the 22 study participants having been hospitalized within the six months prior to 
completing the cost diary.  These results are similar to those reported by Chan and 
colleagues in 201217 who found the average monthly cost of community-based PrU ulcer 
management was $4745 and 62% of these costs were due to hospitalization, 15% due to 
healthcare provider costs, and 16% non MOHLTC costs.   
Despite the similarities in percentages of both studies, our study estimated a monthly cost 
that was $2842.93 higher than the monthly cost reported by Chan et al, 2012 when 
converted to 2017 Canadian dollars.   This difference is likely because we included more 
costs incurred by HCC such as equipment rental and out of pocket health care expenses 
of participants.  In addition, participants included in the present study had serious medical  
conditions (e.g. osteomyelitis) that would have been excluded from previous studies that 
followed relatively healthy participants who were recruited into a randomized controlled 
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trial.  The monthly cost estimate of our study is closer to the $9000/month cost for 
treating a stage III PrU in a case study about a person living in the community with a SCI 
and PrU21   
In evaluating the HCC resource utilization, the median number of nursing visits was 17 
per month with a range of 5-34 nursing visits per patient per month.  Based on known 
practices within HCC in this region, these home visits were likely filled by RPNs who 
were changing the wound dressing.  By comparison monthly visit rates of other 
interdisciplinary team members such as physical and occupational therapists, were very 
sparse.  This is despite the fact that all the participants in the study had significant 
mobility impairments and either used a wheelchair or were bed fast.  This demonstrates 
that patients in the community with a long standing PrU may not receive the 
interdisciplinary team approach recommended in local, national and international best 
practice guidelines.22–24  
There were several limitations to our study.  This report contains only a small sample of 
people who have a chronic PrU and are receiving HCC services in this region.  Most of 
the items included in the cost analysis were based on participant report of the previous six 
months of health care interventions and therefore is subject to recall bias.  We assumed if 
the participant could not recall any resource use in a particular category, that costs were 
zero.  Cost estimates for health care resources the patient did not pay for (hospital and 
HCC costs) have to be based on many assumptions (see Table 15).  The exception was 
for HCC costs where administrative costs were provided for 11 of the 22 subjects.  Costs 
captured did not include government funding for assisted living residences which also 
funds personal support workers (PSW) support for residents.  This would underestimate 
the cost of PSW support required for living with a PrU when assistance for transfers is 
increased to allow for offloading of the PrU.   
4.6 Conclusion 
Cost per month for an individual in the community suffering with a PrU is $8247.48 from 
a societal perspective.   Costs that participants specifically attributed to PrU management 
were $3107.73/month.  Patients with PrUs require high HCC resource utilization for PrU 
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management.  Given the significant costs associated with long term PrUs, early 
intervention using best practices to maximize healing rates is encouraged.   
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5 Cost of a Pressure Ulcer with Underlying Osteomyelitis:  A 
Case Study 
5.1 Introduction 
Pressure ulcers (PrUs) are a common, secondary health complication occurring across all 
sectors of health care including hospitals, long term care, and home and community 
care.1-3  A pressure ulcer is a localized injury to the skin and/or underlying tissue usually 
over a bony prominence, as a result of pressure, or pressure in combination with shear.4  
Stage IV PrUs extend into muscle, bone or joint structures and are associated with 
considerable morbidity and mortality.5  PrUs that remain open for months, or even years, 
are at risk for developing deep infection including osteomyelitis (OSM). 6,7   
Osteomyelitis is inflammation of the bone or bone marrow usually due to infection and is 
present in 17-32% of patients with PrUs.6,7  This high prevalence is quite staggering 
given that OSM underlying PrUs can lead to wound chronicity, complications of flap 
reconstruction surgery, increased length of hospital stay, and increased costs.8-10  
Diagnosis of PrU related OSM is complex given that clinical assessments are often 
inaccurate, and there is no imaging technique (bone scan, X-ray, bone biopsy, MRI) that 
allow for an acceptable discernment between OSM and PrU related bone changes.9,11  
With little agreement amongst physicians about the best test to confirm the presence of  
OSM, patients with suspected OSM can undergo several tests during the diagnostic 
process, incur significant delays in treatment which can result in the progression of the 
bone involvement.  OSM has traditionally been treated with 4-6 weeks of parenteral 
antibiotics which can be insufficient to manage these deep and complex infections.12, 13  
Repeated antibiotic treatments are often required.  Many researchers believe untreated 
OSM will prevent wound closure even with the use of best practices for PrU 
treatment.6,14,15   
Despite important research to date identifying the risks associated with pelvic OSM, most 
of research that has evaluated treatments for OSM have focused on surgical interventions 
such as surgical debridement and flap reconstruction surgery.10, 12, 13   
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There is little known about the cost of treating patients with OSM.  In a study by 
Hirshberg et al in Michigan, USA; 12 individuals with OSM of the pelvis due to PrU 
were examined retrospectively to identify the cost of treatment.  They found the average 
cost to treat an individual with OSM due to PrU was $59,600US and this cost did not 
include the cost of reconstruction surgery.10  Once diagnosed with OSM, the cohort of 12 
individuals required a total of 77 courses of antibiotics and 17 surgical debridement.   The 
majority of debridement occurred in the operating room because of the need for extensive 
resection of the bone.  Only six of the 12 (50%) individuals had successful closure of 
their PrU after receiving surgical flap closure.    
The purpose of this paper was to bring a person lens to cost analysis and document a 
patient’s lived experience and monthly costs associated with the diagnosis and treatment 
of a single case with a PrU and underlying OSM  This cost analysis took a health care 
resource perspective.   
5.2 Methods 
“Ms. P” was a participant in a multi-year knowledge mobilization project aimed at 
implementing best practices into community based PrU care for individuals with spinal 
cord injury (SCI) living in one region of Ontario, Canada.  Within this region, health care 
is coordinated by the South West Local Health Integrated Network (South West LHIN) 
which is funded publicly.  The South West LHIN provides home care services by 
contracting several provider agencies that employ nurses, allied health professionals, as 
well as unregulated support workers.  Participants who consented to participate in the 
study underwent an in-home initial comprehensive PrU assessment by the lead author, 
which included a cost diary.  Ethics approval was obtained from the Western University 
Health Science Research Ethics Board, REB # 106157, the Lawson Health Research 
Institute Research Ethics Board, and the Ethics Committee of participating agencies (see 
Appendix 3).   
Baseline resource utilization data was collected from the individual during an initial 
home assessment using a cost diary.  The cost diary documented expenses incurred for 
the previous six months.  The cost diary included the following items:  (i) emergency 
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room (ER) visits, (ii) inpatient hospitalization stays, (iii) family physician visits, (iv) 
physician specialist visits, (v) clinic visits, (vi) laboratory tests, and (vii) diagnostic 
imaging.  In home sessions were conducted to complete the cost diary each month from 
October 2015 to March 2016 until Ms. P had an MRI to confirm OSM.  Ms. P was 
reassessed in July 2017 and baseline costs for the previous six months were estimated and 
then followed monthly from July to September 2017.  A total of 10 cost diaries were 
completed over a total period of two and a half years.  All cost diary information was 
based on recall.   
Unit costs and resource use in 2017 Canadian dollars are outlined in Table 20.  Home and 
community care (HCC) utilization and costs for this individual were obtained from the 
South West LHIN database for case costing.  HCC costs were provided as cost of 
providers per month and cost of equipment/dressings per month.  HCC costs were only 
provided for this individual at baseline, and therefore monthly HCC costs had to be 
assumed to be consistent for the two-and-a-half-year time period.  Costs for physician 
visits, laboratory tests and medical procedures were obtained from the Ontario MOHLTC 
Schedule of Benefits, 2015.16  Hospitalization costs were obtained from the Ontario Case 
Costing initiative.17 
All cost diary items were entered in to a Microsoft® Excel spreadsheet and average 
monthly costs were calculated.   For baseline cost diaries, the costs were averaged over 
the previous six months to establish a monthly cost estimate.   The average monthly cost 
over 2.5 years was calculated using the mean cost for the 10 cost diaries. 
Table 20:  Costs and Resource Use 
Unit Costs Expressed in 2017 Canadian Dollars Utilization over 2.5 
years 
Variable  Unit Cost  Definition References  
Specialist Physician Visits 
   
 
Family Physician  $                          38.35 Code A004 (1) 2 
Plastic Surgeon  $                          81.10  Code A085 (1) 6 
Physiatrist  $                          39.00  Code H312 (1) 3 
Infectious Disease Specialist  $                        157.00  Code A465 (1) 4 
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5.3 Results 
Ms. P is an active 69-year-old with complete L2-3 paraplegia following a catastrophic 
motor vehicle accident that occurred 22 years ago.  At the time of initial assessment, Ms. 
P reported she was retired, lived alone, and completed her activities of daily living 
(ADLs) independently.  Ms. P estimated that her wound began 5 years ago, and she had 
been receiving daily nursing visits from HCC for dressing changes for the 10 months 
prior to the initial assessment.  Her PrU was over her ischial tuberosity, measured 0.9 
cm2 and gritty bone was palpable in the base of the wound.  Over the past 5 years, Ms. P 
reported that her wound had repeatedly closed for short periods of time but would recur.  
She reported that the copious amounts of drainage and odour coming from her PrU often 
made her feel uncomfortable in public areas such as the grocery store.    
The total cost incurred to date for this single patient was $237,684.69 during the study 
period.  The average monthly cost for this individual with a PrU and OSM was $ 
7,916.70 per month (+/-12,566.96).  The ranges in monthly costs were from $1987.08 to 
$37,873.65 over a two-and-a-half-year period.  Seventy-two percent of total costs were 
due to three hospital admissions for a total of 46 days during the last three months of data 
collection.  These admissions were required to treat septicemia directly caused by 
unresolved OSM.  Eighteen percent of costs were due to HCC resources, and six percent 
due to HCC dressings (Figure 17).    
Wound Specialists  $                          38.35  Code A004 (1) 5 
Hospitalization (per day) 
 
 
 
 
Osteomyelitis, pelvic region  $                     1,239.59  OCCI code 
M8695 
(4) 46 days 
Laboratory test and Diagnostic Imaging (per test) 
  
 
CBC  $                          16.00  Code L393 (6) 3 
Urine Culture  $                            7.00  Code L641 (6) 1 
Wound Swab  $                          25.00  Code L628 (6) 3 
PICC line  $                        168.00  Code Z456 (1) 5 
MRI  $                          48.35  Code J163 (1) 2 
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Figure 17:  Allocation of Monthly Costs 
 
Ms. P was clinically diagnosed with OSM during the initial assessment; however, an 
MRI to confirm diagnosis required a waiting period of 5 months.   Ms. P was referred to 
an infectious disease specialist and plastic surgeon for surgical debridement to assist with 
management of her OSM.  Ms. P reported having multiple courses of long term 
intravenous antibiotics while being treated for OSM and requiring five peripherally 
inserted central catheters (PICC) lines.  Ms. P was also receiving synthetic erythropoietin 
injections 3x/week to increase her production of red blood cells.   
After following Ms. P for two years, she continued to have two PrUs present.  She 
developed a second PrU during one of her hospital admissions and at the time of the last 
re-assessment  she was treated by HCC with negative pressure wound therapy (NPWT) 
applied to both PrUs.  Ms. P was no longer independent with her bed transfers due to her 
inability to use a sliding board.  She required use of a hoyer lift with an out of pocket 
expense of $4000 for installation.  She was unable to drive herself and required personal 
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support for her ADLs and iADLs due to her PrUs.  This was a drastic decline in her 
functional independence compared to her initial assessment in October 2015.   
5.4 Discussion 
To our knowledge, this is the only prospective study reporting patient level data on the 
cost of living with a PrU complicated by OSM.  The cost of pelvic OSM treatment from a 
public payer perspective is close to $8,000.00 per month for this individual.  This cost is 
significant with most of costs being due to hospital admission.  Most significantly, this 
case study highlights the significant impact this complication of PrU has on the quality of 
life and independence of an individual living with PrU.   Unfortunately, the OSM was 
still present in this individual and her PrU were not healed, therefore the costs continue, 
and her life continues to be impacted greatly.  
Ms. P had three hospital admissions within two months over the two-and-a-half-year 
observation period.   This is like the results found by Bodavula et al who completed a 
retrospective review of 220 individuals who were admitted to a teaching hospital in 
Missouri, Illinois with pelvic OSM.  They reported that one third of individuals had two 
or more readmissions to hospital over the course of one year.18   At the conclusion of our 
study, Ms. P had undergone six debridement procedures by the plastic surgeon in the out-
patient hospital clinic.  No plans for further surgical debridement had been established. 
There is much debate about the type and duration of antibiotics and whether surgical 
intervention is needed to resolve OSM12–15,19,–20.  Unfortunately, there are few studies that 
have evaluated the effectiveness of treatments of OSM  
Diagnosis of OSM underlying PrU has also been challenging with different methods such 
as plain film x-ray, MRI, and bone biopsy being reported in the literature.11,21,22  As a 
result many patients undergo several different diagnostic tests and must deal with 
conflicting results.  Protracted course of OSM diagnosis results in delays in initiating 
treatments.  Unresolved OSM has the potential to cause further bone involvement and 
puts the patient at greater risk of septic shock and even death.  .   
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At the time of Ms. P’s initial assessment where OSM was suspected, she reported having 
had her PrU for five years with periods of short term closure. She had been receiving 
daily dressing changes due to copious drainage for 10 previous months.   Ms. P was 
clinically diagnosed by a specialized team at a local regional rehabilitation centre.  Ms. P 
continued to wait a further five months for an MRI to radiologically diagnose OSM.  Our 
case study demonstrated that pelvic OSM underlying PrUs is a clinical condition that is 
difficult to diagnose, as well as treat.  
 In a recent study by Andrianasolo and colleagues, 61 individuals with PrU-related OSM 
were evaluated.  Patients underwent surgical debridement with flap reconstruction 
surgery 6.6 weeks after debridement.13  All of the individuals required intravenous 
antibiotics for a mean total of 19.8 weeks.  Fifteen treatment failures (23.4%) were 
diagnosed 12.4 weeks after flap coverage, with additional surgical procedures required in 
14 cases (93.3%).  Four patients died, including 2 deaths related to PrU-related infection.  
The authors concluded that PrU-related OSM outcomes are poor with an overall failure 
rate approaching 25%. Unfortunately, surgical intervention is not always an option for 
individuals with OSM because of a lack resources and expertise.  Due to limited access 
for surgical intervention, pelvic OSM can result in a lifelong disease with a high risk of 
death from septic shock.   
The cost in our case study is higher than previous monthly estimates found by Chan et al 
of $4745.00 to treat community dwelling individuals with SCI and PrUs.23  Further 
increasing the discrepancy is that our cost estimate only considers public costs, whereas 
Chan’s study estimated costs from a societal perspective.   Additionally, our findings may 
be an underestimate of costs since it is based on Ms. P’s recall.  High rates of health care 
resource utilization have been observed in the literature for individuals with SCI, and this 
increased resource use is commonly due to secondary complications such as PrUs.(24–
26)  In our case study, Ms. P was observed to have only two family physician visits over 
two and a half years which is atypical for an individual with SCI and a PrU in reference 
to the literature.25   
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There is a high cost associated with OSM management in the community, and an even 
higher cost when individuals are offered surgical intervention such as flap coverage.  Our 
case study was an accurate portrayal of individuals who live with PrU and OSM since 
opportunities for surgical intervention and the convalescence required post operatively 
are scarce in many locations in Ontario, Canada.  This case study demonstrates the 
clinical reality that PrU with OSM are often a lifelong disease requiring high HCC 
resources and frequent hospital admissions for septic infection in immunocompromised 
populations such as people with SCI.   
5.5 Conclusion 
Costs associated with treating PrUs and OSM in the community are significant.  A 
conservative estimate based on this case study is $8,000 per month per individual. The 
cumulative costs from a public payer perspective are staggering considering the 
challenges of curing OSM in individuals with PrUs.  More needs to be done to prevent 
this devastating consequence of PrU including ensuring evidence informed PrU 
treatments that are known to promote rapid closure of PrUs.   
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6 Thesis Discussion 
This research was completed as part of a large, knowledge mobilization project with the 
aim of increasing the use of electrical stimulation (E-Stim) as evidence-based practice for 
the treatment of pressure ulcers (PrUs).  This large, multifaceted project was directed at 
introducing practices that would improve wound healing outcomes for patients living 
with PrUs.  Studies described in this thesis focus on two components of this research: an 
evaluation of an education program and cost analyses of pressure ulcer care and E-Stim 
use in a community located in South-western Ontario, Canada.   
Chapter 2 reported on the outcomes on an education program developed to train health 
care providers on the use of E-Stim for the treatment of PrUs.  The aim of the study was 
to determine if an online E-Stim education program can increase provider’s knowledge 
and change attitudes and practice about  the use of E-Stim to stimulate healing of chronic 
pressure ulcers.  Results suggest that knowledge about E-Stim can be improved via a 
customized online education program.  Measurement of attitudes that determine health 
care providers view for the use of E-Stim also improved with the educational program.  
Further revealed was that clinicians support the use of E-Stim for the treatment of PrUs, 
however additional hands-on training may be required to change practices.    
While some attitudes were changed after completing online educational modules, certain 
other attitudes required completion of a hands-on workshop.   Despite significant 
improvements in knowledge and attitudes about E-Stim, very few participants reported to 
the research team that they used E-Stim in their practice. While this result is not entirely 
unexpected, it suggests that further work is needed to influence practice.  It also suggests 
other barriers exist that interfere with a clinician’s ability to put new knowledge into 
practice. 
Another barrier to implementation of an advanced wound care therapy is the perception 
that it is too costly.  Chapters 3-5 investigate the outcome of cost as part of the E-Stim 
Collaboration Project.  In Chapter 3 a cost analysis was conducted to evaluate the cost 
effectiveness of using E-Stim for the treatment of PrUs.  Decision analytic modelling was 
used to evaluate the cost per quality adjusted life year of E-Stim and to compare the cost 
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effectiveness of this novel therapy  to an advanced therapy commonly adopted in practice 
called negative pressure wound therapy (NPWT).  E-Stim was found to be a dominant 
treatment over standard wound care (SWC) meaning it is a less costly and more effective 
treatment than SWC.  By comparison a second decision analytic model was developed to 
compare NPWT to SWC and found adding NPWT was not cost effective compared to 
SWC.  The cost analysis determined that E-Stim is a cost-effective treatment for PrUs.   
Chapters 4 and 5 outline the costs associated with individuals who have a PrU from 
MOHLTC and societal perspective.  Using cost diaries and specific case costing data, the 
monthly costs for a cohort of 22 community dwelling patients with PrU who were 
receiving HCC.   The average monthly cost was calculated to be $8247.48 per patient .  
Chapter 5 provide a case example of the impact when OSM develops in unresolved PrU.  
Needless to say, the cumulated costs and health care resources utilized to diagnose and 
treat someone who has a PrU that becomes complicated with OSM are astronomical.  Not 
to mention the devastating effects that having OSM has on a patient’s quality of life.   
Considering participants in this study had their PrU for an average of 21 months, societal 
costs for unhealed PrU are enormous.  This economic evidence provides the kind of 
justification that many health care decision makers require before implementing 
advanced therapies like E-Stim.   
This thesis summarizes challenges in implementing pressure ulcer best practices fot two 
main practice drivers: education and costs.  This research was guided by the KTA and 
NIRN frameworks using a standardized approach to implementation, adaptation, and 
practice change using PDSA cycles.  Despite this approach to implementation, we were 
unable to demonstrate a significant change in practice for the use of E-Stim in the 
community.  From this work, three key recommendations have been highlighted for 
future implementation projects.  The first recommendation is to ensure that timing for 
implementation is appropriate.  During the time of the E-Stim Collaboration Project, 
significant government structural changes were occurring within the South West LHIN 
which resulted in competing priorities and unclear stakeholder roles.  The second 
recommendation is to engage stakeholders who are interested and willing to invest a 
significant amount of time towards the implementation initiative.  Thirdly, establish key 
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aspects of the pressure ulcer care prior to implantation.  For example, the training 
outlined in chapter 2 should have been completed prior to E-Stim implementation. A 
detailed account of the E-Stim Collaboration Project implementation challenges, barriers 
and facilitators is outlined in the thesis by Lala (2018).1  
Implementation of best practices is important, however very challenging.  During our 
research, we felt we had removed barriers identified by clinicians, such as lack of 
education and lack of resources, and maximized facilitators that had been identified at the 
beginning of the project.  However, community engagement for the use of E-Stim 
continued to be elusive.  An area of exploration for the increase in E-Stim use may be 
that of mentorship in a clinical setting.  Establishing not only online and hands on 
education, but also mentorship may increase clinician’s confidence in delivering this 
intervention to patients.  Increased awareness of wound care interventions, specifically at 
nursing and physiotherapy schools, could include E-Stim for wound treatment as an early 
intervention given that it is a best practice intervention.  We were also limited in our 
study due to ethics the ability to advertise at a patient level.  Engaging patients and 
increasing the awareness for the use of E-Stim at a public level may also be a potential 
driver for change.   
This thesis demonstrates that educational programs are an important intervention to 
increase the awareness of best practices, however education is not enough.  Despite the 
provision of high level evidence that E-Stim is effective to speed the healing of PrUs, we 
did not see a significant change in practice.  When the cost of best practice treatment 
interventions was evaluated, E-Stim was shown to be dominant by being less costly and 
more efficient when compared to SWC treatments.  This further strengthens the need to 
increase the clinical use of E-Stim as a treatment intervention.  Chapters 4 and 5 further 
show that when best practices are not utilized, PrUs progress to become a large financial 
burden to both the health care system.  
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Appendix 2:  Letter of Information and Consent- E-Stim Education Study 
 
PARTICIPANT 
LETTER OF INFORMATION 
 
Title of the study: Evaluation of an Electrical Stimulation Therapy Education Program for the 
Healing of Chronic Wounds 
Primary Investigator: Pamela Houghton, PhD 
Co-Investigators: Lyndsay Orr, MClSc; Paul Holyoke, PhD; Jillian Brooke, MClSc; Deena Lala, MSc  
You are being invited to participate in a research study as a health care provider receiving 
education on the use of electrical stimulation therapy (EST) for the healing of chronic wounds.  
To decide whether or not you want to take part in this research study, you should understand 
what is involved. This form will provide you detailed information about the research study.  
Once you understand the study, you will be asked to sign the form at the end of this information 
letter if you wish to participate. 
 
PURPOSE OF THIS STUDY 
Chronic, non-healing wounds are one of the most common secondary health complications 
among individuals with immobility or those who require use of a wheelchair. When skin 
breakdown occurs, it limits people’s ability to participate in activities and increases the time 
they spend in bed, leading to decreases in quality of life.  Multiple best practice guidelines 
recommend the use of EST to promote the closure of chronic wounds.  EST promotes wound 
healing by increasing the blood supply into the wound and stimulates the wound healing 
process.  Current wound care in individuals with neurological conditions living in the community 
occurs within the home. However, due to limited knowledge and experience with EST, very few 
care providers in the community provide this therapy. 
 
The purpose of this study is to determine whether we can improve health care provider’s 
knowledge, attitudes and practice (KAP) in the use of EST to improve the healing of chronic 
wounds.   
 
WHAT WILL BE ASKED OF YOU IF YOU PARTICIPATE 
If you agree to participate in this study, you will participate in the following: 
1. Questionnaire & Pre-test:  You will be asked to complete a brief questionnaire and a 
knowledge test prior to receiving education on the use of EST.  This test helps us 
understand your current situation and evaluates your level of knowledge.  The 
questionnaire and pre-test should take no more than 15 minutes to complete.   
2. Educational modules:  You will then complete 4-6 educational modules that will be 
available via a secure website or delivered in person by a lecturer.  Either of these 
learning opportunities will take approximately 4-6 hours to complete.  The lectures will 
104 
 
 
be scheduled during a one-day workshop to be provided at a mutually convenient 
location and time.  Online modules will be provided via internet so that they can be 
completed at your own pace.  
3. Hands on Workshops: Once you have completed the education you will be able to 
attend a one-day hands-on practice session that will provide you an opportunity to 
practice application techniques and use equipment needed to use EST for wound care.  
Case based discussions will also occur in small groups that will advance your knowledge 
about EST and promote good clinical judgement that supports safe and effective clinical 
practice.   
4. Post-test:  You will be required to complete a post-test after receiving education on the 
use of EST to evaluate your new knowledge.  This knowledge test will also be repeated 
after the hands on clinical skills session.  The test will take approximately 15 minutes to 
complete. 
5. Upon completion of this education, you will receive a certificate of achievement. 
6. Post-test 2:  You will be asked to complete a second test 6 months after completing the 
EST education.  This test will allow us to evaluate the knowledge you have retained and 
what practices have been incorporated into your clinical practice.  This test will be 
approximately 15 minutes in length.   
 
You will be assigned a unique number identifier in order to track your test results.  The results of 
your test will not influence your ability to receive a certificate of achievement upon completing 
the EST education.  Both post-tests will ask for your feedback about the education received.  The 
feedback you provide in the questionnaires will only be shared with the members of the 
research team.   
 
POSSIBLE RISKS 
There is the potential to encounter technical difficulties when completing the online modules.  
In such cases, technical support will be provided to ensure a working system is available. 
 
BENEFITS 
The benefit for participating in this study is the ability to provide valuable feedback to develop a 
comprehensive educational platform for the use of EST in the healing of pressure ulcers.  The 
information collected in this study will be used to improve future educational resources.   
 
CONFIDENTIALITY 
Only the investigators of this project will have access to your data. We will not share any of your 
test results with anyone other than you.  All information that is obtained during this study and 
that can be used to identify you will remain confidential.  Electronic data (including name, email, 
and survey data) will be saved on a Western University network.   
 
Written data will be securely stored in a locked cabinet in a secure office and personal 
information will be saved on a password-protected computer in the research office at Elborn 
College. 
 
If the results are published, your name will not be used, and no information that discloses your 
identity will be released or published without your specific consent to the disclosure. All data 
will be kept for 5 years following the publication. 
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Representatives of the Western University Health Sciences Research Ethics Board may contact 
you or require access to your study related records to monitor the conduct of the study. 
 
WILL I BE PAID TO PARTICIPATE IN THIS STUDY? 
You will not be compensated for your participation in this study.  
 
VOLUNTARY PARTICIPATION 
Participation in this study is voluntary. You may refuse to participate, refuse to answer any 
questions or withdraw from the study at any time.  At the time of withdrawing from the study, 
we will ask you to briefly provide your reasons for leaving the program.  You do not have to 
provide this feedback.  In addition, you will have the decision to remove or allow your data to 
continue to be used for research purposes. If you allow the researchers to use your data, that 
data will remain with the research team.  
 
QUESTIONS OR CONCERNS? 
If you have questions about the research now or later, please feel free to contact the following: 
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PARTICIPANT 
CONSENT FORM 
 
 Title of the study: Evaluation of an Electrical Stimulation Therapy Education Program for the 
Healing of Chronic Wounds 
Primary Investigator: Pamela Houghton, PhD 
Co-Investigators: Lyndsay Orr, MClSc; Paul Holyoke, PhD; Jillian Brooke, MClSc; Deena Lala, MSc  
 
 
 I have read the letter of information thoroughly. I have had the opportunity to ask 
questions and all of my questions have been answered to my satisfaction. I agree to 
participate in this study. 
  
I prefer the researchers contact me through email. 
  
 
 
________________________________ 
Participant Name (Print) 
 
___________________________________________                         
_____________________________ 
Participant Signature                Date (MM/DD/YYYY) 
 
If verbal consent is obtained in lieu of a signature, the person obtaining consent will initial here: 
______ 
 
I confirm that I have explained the nature and purpose of this study to the participant named 
above.  
I have answered all questions.  
 
________________________________ 
Person Obtaining Consent Name (Print) 
 
_____________________________________________                         
_____________________________ 
Person Obtaining Consent                Date (MM/DD/YYYY) 
 
Copy of Study Results 
I would like a copy of the study results: Yes     No  
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Appendix 3:  HSREB E-Stim Collaboration Project 
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Appendix 4:  Letter of Information and Consent- E-Stim Collaboration Project 
 
 
PARTICIPANT 
LETTER OF INFORMATION 
 
Title of the study: Best Practice Implementation of Electrical Stimulation Therapy for Healing 
Pressure Ulcers in Community Dwelling Individuals with Spinal Cord Injury 
Primary Investigator: Pamela Houghton, PT, PhD 
Co-Investigators: Dalton Wolfe, PhD; Deena Lala, MSc;  Anna Kras-Dupuis, CNS;  Patrick Potter, 
MD; Eldon Loh, MD; Lyndsay Orr, PT, MClSc; Jacqueline Marsh, PhD; Katie Mairs, MSc; Anne 
Shantz, RN. 
 
Sponsors: Rick Hansen Institute  
 
You are being invited to participate in a research study because you have a condition that limits 
your mobility and/or requires you to use a wheelchair, and you are currently experiencing a 
pressure ulcer. To decide whether or not you want to take part in this research study, you 
should understand what is involved. This form will provide you detailed information about the 
research study, which will also be discussed with you in person. Once you understand the study, 
you will be asked to sign the form at the end of this information letter if you wish to participate. 
 
PURPOSE OF THIS STUDY 
Pressure ulcers are one of the most common secondary health complications among individuals 
who have a condition that makes it difficult to walk. When skin breakdown occurs, it limits 
people’s ability to participate in activities and increases the time they spend in bed, leading to 
decreases in quality of life.  
 
Many guidelines recommend the use of electrical stimulation therapy (EST) to promote the 
closure of pressures ulcers. EST is a therapy used alongside standard wound care that mimics 
the natural electrical current of the skin to stimulate the wound healing process. However, due 
to limited knowledge and experience with EST, very few care providers in the community 
provide this therapy. 
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The purpose of this study is to determine whether we can successfully develop a program that 
includes EST to improve the healing of pressure ulcers in individuals who have a condition that 
makes it difficult to walk.   
 
WHAT WILL BE ASKED OF YOU IF YOU PARTICIPATE 
If you agree to participate in this study, you will participate in the following: 
7. Pre-assessment: You will be provided a unique user name and password for a private 
and secure website to complete the pre-assessment form related to your current and 
past medical history. 
8. A researcher and/or qualified clinician will arrange a visit in your home where he/she 
will review the medical history form that you completed and perform a wound 
assessment. We will take a photo of the wound and surrounding skin. This image will 
assist in documenting changes in the wound status and lends important information 
about how well the wound treatment is working. When taking these visual images of 
the wound, a measuring ruler with your patient ID number and the date will be included 
and the image will focus only on the area of the skin affected by the ulcer. Neither your 
name nor any information that might reveal your identity will be contained in the 
wound photograph. You may request at any time to have the photographs destroyed. 
9. Assessment: You will undergo a comprehensive assessment by a team of health care 
professionals such as a physician, registered nurse, physical therapist, occupational 
therapists, social worker, and registered dietician. The assessment will include reviewing 
any existing medical concerns and evaluating the wound size and appearance.  
10. Care plan: A conference call will be set up between the team of health care 
professionals, the study participant, all members of the participants care team in the 
community (including family members, attendant services, and community care 
providers), and any relevant researchers..  The care team will work with you to develop 
a personal care plan that includes an EST treatment plan and schedule. EST is a therapy 
used to deliver electrical current at low levels directly to the wound using specialized 
electrodes and equipment, which will be provided to you at no cost.  A trained person 
will apply EST to the wound for 30-90 minutes at least 5 times a week. There is a 
possibility that EST may not be suitable for you; in this case, you will still be provided a 
customized pressure ulcer treatment plan that is based on Canadian best practice 
guidelines.   
11. Community follow-up: Based on the agreed care plan, you will be followed by members 
of your community care team according to a pre-determined service plan available via 
South West CCAC. This may include personal support workers, care attendants, family 
members, nurses, physical and occupational therapists, dietician, and psychologist or 
social workers supported by members of the research team. 
12. Over the course of this study, you will be able to access educational resources and learn 
as much as you want about pressure ulcer care and electrical stimulation therapy.  
13. An evaluation of costs associated with your health care will occur by tracking your 
equipment and health care services over the study period. This will be compared to 
costs associated with your pressure ulcer care prior to study enrolment. This will involve 
completing a cost diary and quality of life questionnaire (called EQ-5D-5L) at the 
beginning of the study, monthly until the ulcer heals, or 1 year, or until study 
completion, whichever comes first.  We may also need to check your health records to 
accurately estimate costs associated with your health care.    
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14. You will be asked to complete a survey by phone or on the electronic platform to 
describe your experiences with the program.  You may elect to complete this survey and 
questionnaire on hardcopy. If this is the case, the researchers will mail you a copy with a 
stamped envelope included so you can mail the survey back to us. 
 
If you feel uncomfortable using an electronic system to store your medical information, you can 
choose to complete the pre-assessment forms and research surveys using hardcopy.  
 
STUDY TECHNOLOGY 
Multiple electronic systems are commonly used by health care professionals and community 
agencies to store patient information and order medical tests. Unfortunately, not all of these 
systems are linked or allow all users access. CHAYA is a web-based platform that allows for 
patients and care providers at Parkwood Institute and in the community to share medical 
information and communicate using a single system. CHAYA will also provide you access to 
current resources that provide information and helpful hints about recommended best practices 
in the area of pressure ulcer care.  There is also information about why, when and how to apply 
electrical stimulation therapy.  For this study, you will have access to this educational site using 
your existing home computer and Internet connection. If you do not have a computer, you will 
be provided a tablet or laptop. CHAYA can be launched directly from an Internet browser and 
you may login to your profile using a secure username and password. 
 
All electronic personal health information (ePHI) such as name, address and email are encrypted 
according to the Advanced Encryption Standard. CHAYA uses a secure socket layer (SSL), which 
means that all the data sent through the system is encrypted to protect the privacy and 
confidentiality of your information. Users who attempt to access data, for which they do not 
have approved access, will be denied and their attempts will be logged and flagged.   
 
Individuals who will have access to your ePHI include members of your care team including 
providers at Parkwood Institute and in the community, and relevant members of the research 
team. The feedback you provide in surveys and questionnaires will be shared with members of 
the implementation committee, the investigators and their research team.  However, this 
information will not be linked to your personal information (i.e. name).  You will be assigned a 
unique ID when you login to the password protected site and answers to the surveys and 
questions will be summarized and collated to reduce the chances that your comments will be 
identified.      
 
There will be many times in this study where the researchers will need to contact you. If you 
prefer, we ask that you provide us your email address. Researchers will only email you to 
schedule appointments and send reminders to complete study forms. Sensitive personal or 
health information will be not be communicated through e-mail.   
 
POSSIBLE RISKS 
There are potential discomforts associated with wound care (e.g. pain associated with dressing 
changes and debridement). However, these are standard clinical practices in wound care. There 
are also risks associated with the use of EST, but they are minimal. Potential risks include skin 
irritation (i.e. redness, and itchiness) under the electrodes, pain, infection or further breakdown 
of the wound, and electric shock or surge if the EST device fails. You may also be asked to get a 
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blood test to assess your nutrition.  Possible side effects include pain and bruising at the site of 
the needle hole. Bleeding and infection may also occur, but these complications are very rare. 
 
There is also the potential to encounter technical difficulties when using CHAYA. In such case, 
technical support will be available. 
 
If you agree to e-mail communication, you need to understand the risks of using e-mail. The 
security of e-mail is not guaranteed. Messages sent to, or from, researchers may be seen by 
others using the Internet and e-mail can be accidently forwarded. 
 
BENEFITS 
There are possible benefits for participating in this study. You will receive a full work up of your 
wound and a specific care plan by an interdisciplinary team who have advanced training in 
wound care and EST treatment. You will also receive timely access to care providers in the 
community, equipment and supplies (e.g. EST). During this study, you will have access to 
resources that may contribute to your understanding of pressure ulcers and EST. In addition, the 
information collected will help identify the barriers and facilitators of this program. This 
information will be essential for the development of future programs that incorporate EST for 
managing pressure ulcers, and improve access to health care services for individuals with SCI. 
 
CONFIDENTIALITY 
All information that is obtained during this study and that can be used to identify you will 
remain confidential. Electronic data (including name, email, and survey data) stored in CHAYA 
will be encrypted and stored on a secure server at Lawson. Your information will be sent to 
Lawson directly from your home computer or tablet through a secure network.  To ensure 
privacy of your data, do not share your username and password with anyone that should not 
have this information. The network is managed by an outside company who may occasionally 
need to perform maintenance and troubleshoot problems with the online network; however, 
your personal health information is completely encrypted and will not disclose any information 
to them.  
 
Written data will be securely stored in a locked cabinet in a secure office and personal 
information will be saved on a password-protected computer in the research lab. 
 
If the results are published, your name will not be used, and no information that discloses your 
identity will be released or published without your specific consent to the disclosure. 
 
Representatives of the Western University Health Sciences Research Ethics Board may contact 
you or require access to your study related records to monitor the conduct of the study. 
 
WILL I BE PAID TO PARTICIPATE IN THIS STUDY? 
You will not be compensated for your participation in this study. However, any travel or other 
expense you incur as a result of participating in this study will be reimbursed.  
 
VOLUNTARY PARTICIPATION 
Participation in this study is voluntary. You may refuse to participate, refuse to answer any 
questions or withdraw from the study at any time with no effect on your future care. If you 
choose to not participate in this study, you will continue to receive usual care or your current 
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care regimen.  At the time of withdrawing from the study, we will ask you to briefly provide your 
reasons for leaving the program.  You do not have to provide this feedback.  In addition, you will 
have the decision to remove or allow your data to continue to be used for research purposes. If 
you allow the researchers to use your data, that data will remain with the research team.  
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PARTICIPANT 
CONSENT FORM 
 
Title of the study: Best Practice Implementation of Electrical Stimulation Therapy for Healing 
Pressure Ulcers in Community Dwelling Individuals with Spinal Cord Injury 
Primary Investigator: Pamela Houghton, PT, PhD 
Co-Investigators: Dalton Wolfe, PhD; Deena Lala, MSc; Anna Kras-Dupuis, CNS; Patrick Potter, 
MD; Eldon Loh, MD; ; Lyndsay Orr, PT, MClSc; Jacqueline Marsh, PhD; Katie Mairs, MSc; Anne 
Shantz RN 
 
Sponsors: Rick Hansen Institute  
 
 I have read the letter of information thoroughly. I have had the opportunity to ask 
questions and all of my questions have been answered to my satisfaction. I agree to 
participate in this study. 
  
I agree to allow wound photographs to be obtained by my wound care team and used for 
the purpose of documenting changes in my wound.  
 
I prefer the researchers contact me through email to schedule appointments and send 
reminders. My email address is: ____________________________________ 
 
 
________________________________ 
Participant Name (Print) 
 
___________________________________________                         
_____________________________ 
Participant Signature                Date (MM/DD/YYYY) 
 
If verbal consent is obtained in lieu of a signature, the person obtaining consent will initial here: 
______ 
 
I confirm that I have explained the nature and purpose of this study to the participant named 
above.  
I have answered all questions.  
 
________________________________ 
Person Obtaining Consent Name (Print) 
 
_____________________________________________                         
_____________________________ 
Person Obtaining Consent                Date (MM/DD/YYYY) 
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Appendix 5:  Chapter 3 Unpublished Data 
Forrest Plot Data, Pressure Ulcers 
7 studies; 412 wounds / risk on healing: 139 (= 42,4%); 57,2% in the ES group & 21,3% 
in the SWC group. 
 
  
Study or Subgroup
Adunsky 2005
Asbjornsen 1990
Baker 1996
Griffin 1991
Houghton 2010
Kloth 1988
Wood 1993
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.78; Chi² = 20.17, df = 6 (P = 0.003); I² = 70%
Test for overall effect: Z = 2.18 (P = 0.03)
Events
5
0
68
3
11
9
43
139
Total
35
7
125
8
16
9
43
243
Events
3
2
24
2
4
0
1
36
Total
28
9
67
9
18
7
31
169
Weight
15.5%
6.6%
23.7%
14.0%
19.3%
7.3%
13.7%
100.0%
M-H, Random, 95% CI
1.33 [0.35, 5.10]
0.25 [0.01, 4.50]
1.52 [1.06, 2.17]
1.69 [0.37, 7.67]
3.09 [1.23, 7.80]
15.20 [1.03, 223.37]
21.09 [4.42, 100.64]
2.61 [1.10, 6.18]
Experimental Control Risk Ratio Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours control Favours ES
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Appendix 6:  Chapter 4 Costing Reference Table 
 
 
 
 
ParticipantAge Sex ? OSM Level Injury SCI(years) Wound Duration(months)SA Site Stage CCAC ER Hosp FP Specialist Clinics Tests Meds Additional CostsHCP private payWage lost HC lost Total Equipment
1001 47 Male L1 Incomplete L1 0.5 1 1.4 coccyx DTI 1,984.95$    119.64$  -$                6.39$      26.17$    -$        10.78$    110.10$     1.33$      -$            -$            -$              2,259.36$      10,150.00$    
1002 42 Male C6-7 Complete C6-7 18 8 34 IT III 734.09$       119.64$  1,545.90$      6.39$      46.30$    -$        8.00$      106.44$     -$        -$            -$            -$              2,566.76$      2,790.00$      
1003 69 Female y L2-3 Complete L2-3 22 60 0.9 IT IV 1,925.83$    -$        -$                6.39$      39.06$    -$        2.67$      363.78$     0.67$      -$            -$            -$              2,338.39$      43,900.00$    
1004 65 Female T5 Incomplete-spinal stroke 0.3 4 8.1 R buttock III 1,984.95$    -$        75,040.00$    -$        -$        -$        -$        642.60$     -$        -$            -$            -$              77,667.55$    -$                
1005 45 Male C6-7 Complete C6-7 21 60 0.8 IT III 1,538.00$    59.82$    -$                12.78$    12.89$    25.57$    44.93$    682.16$     3.33$      -$            -$            -$              2,379.48$      -$                
1006 35 Male y C4 Complete C4 6 48 0.2 IT IV 1,077.00$    59.82$    770.34$          12.78$    39.63$    38.35$    5.34$      1,384.84$ 4.67$      3,040.00$ -$            -$              6,432.77$      -$                
1007 70 Male y T Incomplete-spinal stroke8 15 1.7 IT IV 2,249.00$    -$        -$                12.78$    6.39$      -$        30.67$    601.67$     8.33$      -$            -$            -$              2,908.85$      1,400.00$      
1008 63 Male Cauda Equina 3 24 11.6 heel unstageable 1,275.24$    59.82$    1,033.56$      19.18$    65.76$    -$        4.17$      102.60$     2.00$      -$            -$            -$              2,562.32$      44,860.00$    
1009 36 Male T5-6 Complete T5-6 8 60 14.8 Coccyx IV 824.50$       59.82$    -$                19.18$    39.63$    6.39$      3.84$      60.00$       -$        -$            -$            336.43$       1,349.78$      3,000.00$      
1010 41 Male y T4 Complete T4 5 72 0.3 buttock III 1,031.20$    59.82$    -$                12.78$    19.91$    -$        8.00$      78.90$       0.67$      -$            -$            3,129.60$    4,340.88$      3,100.00$      
1013 81 Female y T8 Complete T8 28 36 2.7 IT IV 1,984.95$    -$        -$                -$        13.33$    -$        -$        69.60$       -$        -$            -$            2,347.20$    4,415.08$      4,000.00$      
1014 53 Male T4 Complete T4 35 1 3.8 IT III 1,984.95$    -$        -$                25.57$    107.70$  12.78$    10.47$    33.17$       1.67$      -$            -$            -$              2,176.31$      300.00$          
1016 41 Male y T12 Complete T12 16 39 4.2 IT IV 1,984.95$    59.82$    -$                19.18$    -$        -$        31.91$    -$            -$        -$            -$            1,564.80$    3,660.66$      850.00$          
1017 63 Male C5-6 Complete 1 4 13.9 IT III 1,984.95$    119.64$  25,540.67$    -$        -$        -$        -$        116.01$     -$        -$            -$            -$              27,761.27$    -$                
1018 87 Male y Cauda Equina 17 10 4.3 IT IV 1,984.95$    -$        858.83$          6.39$      8.33$      -$        1.17$      27.90$       1.33$      -$            -$            -$              2,888.91$      400.00$          
1019 47 Male C3 Complete C3-4 31 3 7 Coccys IV 4,842.37$    -$        9,035.98$      -$        -$        -$        -$        47.70$       -$        -$            -$            -$              13,926.05$    -$                
1020 69 Female Buttock PrI, depression episode3 1.7 buttock III 1,984.95$    -$        -$                6.39$      -$        -$        -$        239.70$     -$        -$            -$            -$              2,231.04$      -$                
1024 61 Female C5-6 Complete 2 3 1.1 R 5th toe IV 5,248.00$    59.82$    -$                12.78$    6.50$      -$        24.50$    315.40$     -$        2,000.00$ -$            -$              7,667.00$      7,300.00$      
1026 69 Male L BKA 3 6.5 L BKA III 1,089.21$    -$        -$                6.39$      45.15$    -$        -$        39.61$       1.33$      -$            -$            782.40$       1,964.09$      -$                
1027 78 Female CVA 4 8 Shoulder IV 1,984.95$    179.47$  -$                -$        30.10$    -$        3.55$      -$            -$        -$            -$            -$              2,198.06$      800.00$          
1028 74 Female Parkinson's-Lewy Body 6 10.88 Coccyx IV 1,984.95$    -$        -$                19.18$    -$        -$        1.17$      -$            -$        3,040.00$ -$            -$              5,045.29$      -$                
1029 48 Female T7 Complete T7-8 27 2 7.9 IT III 1,984.95$    -$        -$                12.78$    -$        -$        5.34$      180.00$     -$        -$            521.60$     -$              2,704.67$      8.00$              
Total 248.8 466 145.78 43,668.88$ 957.14$  113,825.28$ 217.32$  506.84$  83.09$    196.48$  5,202.18$ 25.33$    8,080.00$ 521.60$     8,160.43$    181,444.57$ 122,858.00$ 
Mean 58.36364 13.82222 21.18182 6.626364 1,984.95$    43.51$    5,173.88$      9.88$      23.04$    3.78$      8.93$      236.46$     1.15$      367.27$     23.71$       370.93$       8,247.48$      5,584.45$      
SD 15.46284 11.5233 24.22639 7.580844 1,091.89$    52.81$    16,591.52$    7.57$      27.24$    9.80$      12.51$    332.20$     2.03$      964.01$     -$            857.76$       16,549.35$    12,828.19$    
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